Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3001964	-hsvag	— (—)	1296	1953	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

L04AD Calcineurin inhibitors

236

111

22.37

318.82

3.0

1.6

—

Transplanted organ and tissue status

247

32.37

307.65

2.9

1.3

—

ILD medications: immunosuppressive drugs

411

539

7.15

265.91

2.2

1.2

—

Viral infections characterized by skin and mucous membrane lesions

345

413

8.46

265.43

1.5

—

Herpesviral [herpes simplex] infections

251

210

12.18

250.47

1.3

1.4

—

Viral infections characterized by skin and mucous membrane lesions

494

777

5.48

238.75

1.5

—

L04AA Selective immunosuppressants

241

227

10.84

222.50

2.8

1.3

—

Herpesviral [herpes simplex] infections

170

19.94

219.81

1.4

1.6

—

Keratitis

284

350

8.23

213.68

1.3

1.5

—

Disorders of sclera, cornea, iris and ciliary body

328

605

5.47

167.87

1.3

1.6

—

Other keratitis

149

102

15.02

167.64

1.2

1.6

—

ILD medications: prednisolone, methylprednisolone, prednisone

494

603

4.61

166.48

1.9

1.2

—

ILD, hospital admission 2, with pulmonary infections

114

24.38

160.30

2.9

1.1

—

First line medication for Crohn's disease

485

584

4.51

157.30

1.8

1.2

—

Bacterial infection, other or unspecified

292

423

6.04

157.07

1.7

1.5

—

ILD medications

499

627

4.34

154.99

1.8

1.2

—

Bacterial infection, other or unspecified

302

464

5.54

147.52

1.6

1.5

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

403

518

4.73

145.07

2.0

1.2

—

403

518

4.73

145.07

2.0

1.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

135

21.26

141.05

2.9

1.3

—

ILD, hospital admissions 3, with pneumonia sepsis

24.22

138.80

2.9

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

447

755

3.99

137.00

1.9

1.3

—

Pneumonia, organism unspecified

410

689

4.19

135.81

2.0

1.3

—

Fever of other and unknown origin

284

482

5.28

134.41

1.8

1.3

—

All pneumoniae

447

762

3.94

134.35

1.9

1.3

—

Influenza and pneumonia

462

759

3.89

134.02

1.9

1.3

—

Other respiratory diseases principally affecting the interstitium

154

158

9.92

133.83

2.7

1.3

—

Primary_lymphoid and hematopoietic malignant neoplasms

178

224

8.06

131.77

1.6

1.5

—

Liquid cancers, helper endpoint

218

284

6.76

130.74

1.6

1.5

—

Oral corticosteroids

453

691

3.91

128.82

2.0

1.2

—

Other bacterial diseases

412

692

4.02

127.53

1.7

1.5

—

Other interstitial pulmonary diseases

138

132

10.66

126.11

2.9

1.3

—

Zoster [herpes zoster]

139

136

10.38

124.92

1.6

1.4

—

ILD, hospital admissions

138

134

10.50

124.80

2.9

1.2

—

Interstitial lung disease

138

135

10.42

124.14

2.9

1.2

—

Interstitial lung disease endpoints

138

135

10.42

124.14

2.9

1.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

427

771

3.79

123.08

1.9

1.3

—

Certain infectious and parasitic diseases

354

369

4.82

119.33

1.6

1.3

—

Inflammatory bowel disease treatment related agents

471

738

3.58

116.77

2.0

1.2

—

ILD, hospital admissions 1, main diag only

127

123

10.54

115.09

3.0

1.3

—

Idiopathic pulmonary fibrosis

18.00

112.28

3.4

1.2

—

Other bacterial diseases

407

730

3.55

104.49

1.7

1.5

—

Viral Sepsis

140

175

8.10

104.26

1.6

1.4

—

Implicit viral Sepsis

138

175

7.98

101.54

1.7

1.4

—

Zoster [herpes zoster]

220

439

4.97

100.79

1.6

1.4

—

Herpesviral keratitis and keratoconjunctivitis

22.38

98.74

1.5

1.6

—

Implicit viral Sepsis

166

276

6.07

94.98

1.7

1.4

—

Dialysis, with operation codes

111

119

9.50

93.46

1.6

—

Implicit bacterial Sepsis

188

326

5.15

86.56

1.7

1.5

—

Bacterial Sepsis

206

374

4.74

85.19

1.7

1.5

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

377

768

3.21

84.02

2.2

1.1

—

Dental caries

147

238

5.99

81.88

2.2

1.5

—

Bacterial pneumonia (organism specified)

203

413

4.49

80.24

1.9

1.4

—

Implicit bacterial Sepsis

194

362

4.66

78.96

1.7

1.5

—

ILD-related respiratory insufficiency

23.89

78.93

3.3

1.0

—

Corneal ulcer

116

165

7.11

77.25

1.3

1.5

—

Nephropathy related operations

102

127

8.18

76.36

1.5

1.6

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

363

831

3.02

74.91

1.8

1.4

—

Persons encountering health services for specific procedures and health care

390

802

2.93

72.87

1.7

1.4

—

COPD/asthma related infections

341

518

3.31

72.55

1.7

1.2

—

COPD/asthma/ILD related infections

341

518

3.31

72.55

1.7

1.2

—

Bacterial pneumonia, not elsewhere classified

161

287

4.97

71.24

2.0

1.4

—

Bacterial pneumoniae

168

314

4.74

70.49

2.0

1.4

—

Anogenital herpesviral [herpes simplex] infection

104

8.69

70.13

1.2

1.4

—

Caries of dentine

126

209

5.92

69.68

2.0

1.6

—

Other medical care

183

385

4.30

68.50

1.6

1.4

—

Oxycodone

159

302

4.79

68.10

1.6

1.5

—

Non-Hodgkin lymphoma, all, including Hilmo

112

8.15

67.38

1.5

1.4

—

General symptoms and signs

356

587

3.05

66.93

1.6

1.3

—

Other diseases of blood and blood-forming organs, wide

125

228

5.54

65.10

1.9

1.5

—

Pneumonia due to other infectious organisms, not elsewhere classified

25.05

64.98

1.6

1.2

—

Implicit Sepsis

268

625

3.25

63.91

1.7

1.4

—

Septicaemia

162

346

4.40

63.37

1.8

1.5

—

Bronchitis

371

857

2.73

62.58

1.9

1.3

—

Second line medication for Crohn's disease

238

727

3.29

62.52

1.7

1.5

—

Other septicaemia

147

304

4.68

62.49

1.8

1.5

—

L04AX Other immunosuppressants

233

709

3.30

61.60

1.7

1.5

—

COPD-related respiratory insufficiency

8.69

61.53

2.8

1.2

—

ILD medications: azathioprine

107

7.84

60.29

1.7

1.4

—

Certain infectious and parasitic diseases

203

239

4.27

60.26

1.6

1.3

—

Early onset COPD, excluding more controls

103

7.91

59.43

2.6

1.1

—

369

706

2.71

57.46

1.8

1.2

—

Pneumocystosis

26.56

57.29

1.5

1.3

—

Explicit Sepsis

169

411

3.86

55.52

1.7

1.4

—

Tramadol

260

509

3.15

55.47

1.8

1.4

—

Respiratory insufficiency

13.13

54.37

3.0

1.2

—

Protozoal diseases

18.61

53.57

1.5

1.7

—

Implicit Sepsis

273

691

2.90

53.47

1.7

1.4

—

Asthma, excluding more controls

219

320

3.58

53.17

1.8

1.1

—

Asthma

224

338

3.48

52.52

1.8

1.1

—

Malignant neoplasm

282

574

2.92

52.41

1.6

1.5

—

Abnormal findings on diagnostic imaging of lung

175

469

3.59

52.31

1.8

1.5

—

Azathioprine

128

6.55

51.34

1.7

1.5

—

Acute upper respiratory infections of multiple and unspecified sites

268

701

2.84

50.99

2.0

1.3

—

Any death

216

478

3.25

50.91

1.6

—

Malignant neoplasm, wide definition for exclusion

286

597

2.82

49.97

1.8

1.5

—

Renal failure

169

421

3.57

48.87

1.6

—

Agranulocytosis

121

6.45

46.85

2.0

1.5

—

Renal tubulo-interstitial diseases

289

830

2.60

46.59

1.6

1.5

—

Anaemias

100

113

5.81

46.22

1.9

1.1

—

Heart failure, not strict

244

583

2.85

45.61

1.8

1.6

—

Chronic kidney disease

121

284

4.20

45.36

1.6

1.5

—

Other diseases of pleura

162

409

3.49

45.26

2.3

1.4

—

Asthma, unspecified (mode), excluding more controls

146

285

3.84

44.73

1.7

1.1

—

Asthma (only as main-diagnosis), excluding more controls

190

320

3.40

44.66

1.9

1.1

—

Asthma (only as main-diagnosis)

194

338

3.33

44.37

1.9

1.1

—

Conjunctivitis (acute, non atopic)

129

330

3.92

44.20

1.5

—

Other pulmonary diagnosis

217

341

3.20

44.20

1.6

1.1

—

Infections, IBD-co-morbidities

6.77

44.19

2.2

1.2

—

COPD (mode)

131

5.54

44.06

2.3

1.1

—

COPD differential diagnosis

215

338

3.19

43.77

1.6

1.1

—

ILD differential diagnosis

215

338

3.19

43.77

1.6

1.1

—

Viral pneumonia

7.01

43.57

2.1

1.4

—

Any event in cancer register

293

671

2.58

43.57

1.6

1.5

—

Implicit fungal Sepsis

14.82

43.47

1.7

1.6

—

Fungal Sepsis

14.12

43.45

1.7

1.6

—

Diseases of the eye and adnexa

255

448

2.86

43.42

1.6

1.5

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

213

667

2.87

43.31

1.7

1.5

—

Acute upper respiratory infections

321

813

2.44

43.20

1.8

1.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

266

720

2.61

42.81

1.8

1.4

—

Continuous positive airway pressure

158

5.10

42.74

1.9

1.3

—

Other viral diseases

163

498

3.27

42.44

2.0

1.5

—

Acute bronchitis

156

458

3.35

42.32

2.3

1.4

—

Opioids

292

586

2.59

42.28

1.6

1.4

—

Implicit fungal Sepsis

9.26

42.20

1.6

1.4

—

Excluding asthma or asthma-COPD overlap

213

341

3.14

42.20

1.6

1.1

—

Other viral diseases

136

374

3.65

42.07

2.1

1.5

—

Rare circulating lymphoid malignancy, including Hilmo

17.16

41.99

2.2

1.1

—

Non-follicular lymphoma

7.23

41.93

1.6

1.3

—

Asthma, unspecified (mode)

146

302

3.65

41.78

1.7

1.1

—

Infections with a predominantly sexual mode of transmission

159

451

3.30

41.47

1.4

—

Other acute lower respiratory infections

194

635

2.92

41.46

2.2

1.4

—

Non-Hodgkin lymphoma, all

13.28

40.93

1.4

—

Disorders of eyelid, lacrimal system and orbit

271

823

2.51

40.88

1.6

1.5

—

Neoplasms

245

468

2.78

40.62

1.8

1.3

—

Asthma (mode)

198

338

3.14

40.40

1.7

1.1

—

Mycoses

114

287

4.00

40.23

2.0

1.4

—

Anogenital herpesviral [herpes simplex] infection

8.92

40.21

1.4

1.3

—

Pain, not elsewhere classified

107

260

4.14

39.60

2.2

1.3

—

Any gastric operation

228

400

2.87

39.08

1.7

1.1

—

GASTRO-related operations

228

400

2.87

39.08

1.7

1.1

—

Erysipelas

162

456

3.15

38.82

1.4

1.5

—

Other diseases of the respiratory system

195

4.65

38.60

2.7

1.4

—

Other respiratory disorders and diseases

195

4.65

38.60

2.7

1.4

—

Kidney transplant status

9.39

38.39

1.6

2.3

—

Other disorders of lacrimal gland

129

367

3.53

38.17

1.7

1.4

—

All kidney diseases

303

891

2.33

38.06

1.6

1.5

—

All chronic kidney diseases

179

495

2.97

37.90

1.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

237

847

2.53

37.86

1.6

1.5

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

14.49

37.44

1.2

1.8

—

Condition for Implicit Sepsis (Organ dysfunction codes)

267

757

2.44

37.12

1.8

1.4

—

Failure and rejection of transplanted organs and tissues

58.62

37.01

3.4

1.8

—

Disorders of conjunctiva

270

914

2.38

36.90

1.5

—

All influenza

211

4.38

36.73

2.0

1.4

—

Pulmonary heart disease, diseases of pulmonary circulation

116

316

3.69

36.62

1.9

1.4

—

Asthma-related pneumonia

135

407

3.33

36.37

2.2

1.4

—

Asthma, hospital admissions 3, pneumonia

135

407

3.33

36.37

2.2

1.4

—

Asthma-related pneumonia or sepsis

135

407

3.33

36.37

2.2

1.4

—

Intestinal infectious diseases

293

975

2.29

36.18

1.6

1.5

—

Lymphoid leukaemia

9.50

35.40

2.0

1.6

—

Enlarged lymph nodes

121

5.58

35.39

1.4

1.3

—

Examination and observation for other reasons

192

384

2.90

35.36

1.8

1.3

—

Conjunctivitis

248

862

2.41

35.24

1.5

—

Dermatitis

199

758

2.62

35.13

1.7

1.5

—

Malaise and fatigue

151

389

3.13

34.99

1.6

1.3

—

Dermatitis and eczema

329

941

2.17

34.30

1.6

1.5

—

Care involving dialysis

7.60

33.96

1.3

1.5

—

Asthma, hospital admission 2, infections

200

763

2.58

33.87

1.9

1.4

—

Asthma-related infections

200

763

2.58

33.87

1.9

1.4

—

Provisional assignment of new diseases of uncertain etiology

180

666

2.71

33.83

2.1

1.4

—

Diseases of the skin and subcutaneous tissue

282

598

2.37

33.80

1.7

1.4

—

Codes for special purposes

180

667

2.70

33.74

2.1

1.4

—

Other and unspecified dermatitis

173

631

2.75

33.56

1.6

1.5

—

161

567

2.83

32.82

1.9

1.5

—

Care involving use of rehabilitation procedures

189

666

2.62

32.67

1.7

1.5

—

Acute renal failure

193

4.33

32.64

1.6

1.4

—

Other pulmonary heart/vessel disease

9.92

32.16

2.8

1.2

—

Dyspnoea

263

857

2.27

31.95

1.8

1.4

—

Other inflammation of eyelid

137

5.01

31.87

1.4

—

Secondary right heart disease

10.50

31.63

2.9

1.2

—

Disorders of lacrimal system

140

471

2.98

31.40

1.7

1.4

—

Covid-19 confirmed case

127

409

3.12

30.89

2.2

1.4

—

Metabolic disorders

269

727

2.26

30.85

1.8

1.4

—

Any reimbursement code in KELA

170

289

2.96

30.82

1.7

1.1

—

Erysipelas

185

545

2.60

30.22

1.3

1.5

—

Certain disorders involving the immune mechanism

201

4.11

30.13

2.0

1.5

—

Infections of the skin and subcutaneous tissue

190

761

2.48

29.90

1.5

—

Solid cancers, helper endpoint

228

561

2.41

29.69

1.5

—

Venous thromboembolism

161

583

2.68

29.45

1.5

—

Complications of surgical and medical care, not elsewhere classified

281

902

2.14

29.00

1.6

1.5

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

134

4.31

28.75

1.6

1.2

—

Viral warts

6.29

28.67

2.0

1.4

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

210

3.76

28.67

2.4

1.3

—

Diffuse large B-cell lymphoma, helper endpoint

9.88

28.60

1.6

1.4

—

Diffuse large B-cell lymphoma

9.88

28.60

1.6

1.4

—

Diffuse large B-cell lymphoma, including Hilmo

9.88

28.60

1.6

1.4

—

Complications of medical and surgical care

216

864

2.30

28.47

1.6

1.5

—

Codeine

241

567

2.31

28.22

1.6

1.3

—

Diseases of oesophagus, stomach and duodenum

296

852

2.08

27.64

2.0

1.4

—

Iridocyclitis

197

3.98

27.54

1.3

1.7

—

Symptoms and signs involving the skin and subcutaneous tissue

210

902

2.28

27.47

1.7

1.5

—

Extracorporeal dialysis

7.47

27.17

1.3

1.6

—

Other disorders of skin and subcutaneous tissue

199

756

2.34

27.14

1.8

1.5

—

Autoimmune diseases excluding thyroid diseases

305

809

2.06

27.12

1.4

1.6

—

L01XE Protein kinase inhibitors

7.35

26.75

2.2

1.4

—

Heart failure and antihypertensive medication

150

3.90

26.68

1.7

1.2

—

Osteopathies and chondropathies

172

650

2.47

26.62

1.6

1.5

—

Autoimmune diseases excluding thyroid diseases, strict definition

296

790

2.06

26.20

1.4

1.6

—

Diseases of the respiratory system

154

273

2.83

26.10

1.5

1.1

—

Reimbursement for rheumatic diseases

173

714

2.42

25.93

1.4

1.5

—

Cough

128

431

2.82

25.82

2.0

1.4

—

COPD, hospital admission 2, with asthma infections

101

266

3.27

25.61

2.3

1.4

—

Oedema, not elsewhere classified

270

3.37

25.47

2.0

1.3

—

Drug-induced neutropenia

6.22

25.36

1.8

1.4

—

Early onset COPD

226

3.60

24.86

2.6

1.4

—

Headache

167

544

2.46

24.73

1.5

1.3

—

Infections with a predominantly sexual mode of transmission

111

377

2.95

24.66

1.6

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

278

911

2.02

24.48

1.6

1.5

—

153

4.21

24.39

2.5

1.4

—

Pain in throat and chest

228

627

2.19

24.23

1.6

1.3

—

Multiple myeloma, including Hilmo

9.80

24.14

1.1

1.4

—

Chronic lower respiratory diseases

331

921

1.92

24.04

1.9

1.4

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

301

829

1.98

23.98

1.5

—

Gastrointestinal diseases

165

319

2.60

23.96

1.7

1.2

—

Emphysema

7.57

23.34

2.8

1.2

—

Asthma (diagnoses ohter than nonallergic)

245

1001

2.03

23.28

1.8

1.5

—

Persons encountering health services in other circumstances, wide

312

831

1.94

23.14

1.6

1.5

—

Varicella [chickenpox]

8.43

23.13

2.2

2.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

172

741

2.30

22.95

1.7

1.5

—

Other soft tissue disorders, not elsewhere classified

266

774

2.02

22.90

1.7

1.5

—

Pain in limb

233

746

2.09

22.83

1.7

1.5

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

7.88

22.58

1.5

1.3

—

COPD

123

373

2.70

22.25

2.2

1.4

—

Abnormalities of breathing

238

665

2.08

22.24

1.7

1.4

—

Viral warts

202

3.58

21.96

1.9

1.4

—

Cytomegalovirus infection, IBD co-morbidity

19.04

21.87

3.0

2.4

—

Candidiasis

329

2.96

21.73

1.5

1.4

—

Intestinal infectious diseases

301

907

1.90

21.72

1.5

—

Mycoses

236

1028

2.00

21.65

1.6

1.5

—

Recurrent aphthous stomatitis , including avohilmo

154

3.99

21.65

1.6

1.4

—

Stomatitis and related lesions

209

3.51

21.61

1.6

1.4

—

Other metabolic disorders

137

4.19

21.60

2.7

1.3

—

Pulmonary embolism

289

3.09

21.50

1.6

1.4

—

Vulvovaginal ulceration/inflammation in other diseases

6.28

21.46

1.4

—

Cytomegaloviral disease

18.01

21.46

3.0

2.4

—

Glomerular diseases

182

3.70

21.45

1.2

1.7

—

Other/unspecified cytomegaloviral diseases

24.04

21.43

3.2

2.1

—

Autoimmune diseases related-to ILD

216

904

2.05

21.09

1.3

—

Acute sinusitis

147

573

2.38

21.08

2.0

1.3

—

Pulmonary heart disease

293

3.05

21.01

1.6

1.5

—

Aplastic and other anaemias

128

475

2.52

20.75

1.8

1.5

—

Other chronic obstructive pulmonary disease

116

361

2.66

20.37

2.2

1.4

—

Allergic asthma (mode), excluding more controls

175

3.65

20.30

1.5

1.1

—

Secondary uncertain malignant neoplasm

106

4.56

20.27

1.3

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

131

4.15

20.23

1.3

1.4

—

Codeine or tramadol medication

292

854

1.87

20.09

1.6

1.4

—

Ocular pain

5.05

19.96

1.3

1.5

—

Other disorders of eye and adnexa

159

3.80

19.94

1.3

1.5

—

Symptoms and signs involving the circulatory and respiratory systems

260

667

1.96

19.81

1.6

1.4

—

Secondary and unspecified malignant neoplasm of lymph nodes

5.48

19.77

1.3

—

Asthma and allergy, excluding more controls

4.65

19.42

1.3

1.1

—

Asthma and allergy

4.65

19.42

1.3

1.1

—

Systemic connective tissue disorders

106

401

2.65

19.41

1.4

—

Immunodeficiencies

6.37

19.30

1.4

1.6

—

Other viral diseases, not elsewhere classified

340

2.79

19.14

2.0

1.5

—

Other heart diseases

134

356

2.46

19.10

1.7

1.3

—

Allergic asthma (mode)

183

3.49

19.03

1.5

1.1

—

Candidiasis

142

3.90

18.97

1.8

1.2

—

Cutaneous abscess, furuncle and carbuncle

296

2.92

18.84

1.6

1.4

—

Unspecified acute lower respiratory infection

134

3.98

18.81

2.3

1.3

—

Convulsions, not elsewhere classified

206

3.32

18.74

1.4

1.3

—

Dialysis

7.76

18.72

1.1

2.3

—

Other reaction to severe stress, and adjustment disorders

115

461

2.50

18.72

2.1

1.4

—

Unspecified kidney failure

5.32

18.70

1.5

1.3

—

Other and unspecified anaemias

114

432

2.52

18.68

1.9

1.5

—

Heart failure,strict

134

393

2.41

18.65

1.6

1.5

—

Unspecified privation

114

4.24

18.53

1.4

—

Glomerular disorders in diseases classified elsewhere

110

4.30

18.49

1.2

1.6

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

361

2.69

18.45

1.8

1.4

—

Other anaemias

114

437

2.49

18.14

1.9

1.5

—

Ulcer of lower limb, not elsewhere classified

129

3.98

18.10

1.2

1.4

—

Nausea and vomiting

308

2.81

17.94

1.6

1.4

—

Anxiety disorders, excluding more controls

219

729

1.96

17.93

1.7

1.5

—

Cardiovascular diseases (excluding rheumatic etc)

179

485

2.13

17.72

1.7

1.3

—

COPD related to multimorbidity

104

339

2.60

17.66

2.2

1.5

—

Other viral diseases, not elsewhere classified

227

3.14

17.62

2.2

1.6

—

Myeloid leukaemia

15.96

17.56

1.8

1.4

—

Lung cancer and mesothelioma

4.50

17.50

1.4

1.1

—

DVT of lower extremities and pulmonary embolism

113

462

2.44

17.49

1.7

1.4

—

ILD medications: pirfenidone

33.38

17.24

4.7

1.0

—

Other disorders of urethra and urinary system

177

620

2.06

17.18

1.4

1.5

—

COPD, hospital admissions

116

405

2.43

17.13

2.2

1.5

—

Multiple myeloma and malignant plasma cell neoplasms

6.45

17.12

1.1

1.4

—

Acute tubulo-interstitial nephritis

160

658

2.10

16.91

1.5

—

Disorders of skin appendages

140

640

2.19

16.87

1.7

1.5

—

Complications of procedures, not elsewhere classified

202

866

1.93

16.82

1.2

1.5

—

Osteonecrosis

5.70

16.80

2.1

1.4

—

Special screening examination for infectious and parasitic diseases

215

2.89

16.80

1.1

1.2

—

Other problems related to primary support group, including family circumstances

128

3.83

16.71

2.4

1.5

—

Genitourinary diseases

157

355

2.22

16.64

1.7

1.6

—

Viral conjunctivitis

6.76

16.61

1.2

1.5

—

COPD, early/later onset

116

410

2.39

16.58

2.2

1.5

—

Other diseases of intestines

272

864

1.79

16.57

1.6

1.5

—

Other disorders of cornea

4.78

16.57

1.3

1.5

—

Urticaria and erythema

111

464

2.40

16.56

1.7

1.4

—

Parasetamol

194

485

2.03

16.52

1.6

1.3

—

Disorders of lens

168

504

2.08

16.20

1.9

1.5

—

Persons encountering health services for specific procedures, not carried out

4.90

16.13

1.9

1.4

—

Bleeding

204

761

1.91

15.93

1.7

1.5

—

Seborrhoeic keratosis

216

3.07

15.87

2.1

1.4

—

Polyarthropathies

180

588

2.00

15.81

1.3

1.7

—

COPD, hospital admissions 1, only main diagnosis

294

2.63

15.74

2.4

1.4

—

Chronic gastritis

260

2.86

15.69

2.1

1.3

—

Acute and subacute iridocyclitis

167

3.37

15.67

1.2

1.6

—

Acute myeloid leukaemia and myelodysplastic syndromes

22.59

15.60

2.0

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

213

3.07

15.60

1.4

1.5

—

Symptoms and signs involving the digestive system and abdomen

254

703

1.81

15.59

1.7

1.5

—

Diagnoses used for exclusion with ILD

245

2.91

15.56

2.1

1.4

—

Exposure to unspecified factor

254

1038

1.76

15.45

1.4

1.5

—

Hordeolum and other deep inflammation of eyelid

5.77

15.40

1.8

1.3

—

Heart failure, strict

140

459

2.16

15.17

1.6

1.5

—

Other diseases of urinary system

244

762

1.80

15.14

1.5

1.6

—

Medical observation and evaluation for suspected diseases and conditions

159

385

2.12

15.14

1.8

1.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

160

385

2.11

15.05

1.9

1.3

—

Other heart diseases, wide

235

796

1.81

15.02

1.6

1.4

—

Hard cardiovascular diseases

200

627

1.91

14.94

2.2

1.3

—

Molar incisor enamel hypoplasia

5.87

14.84

2.6

2.0

—

Other bacterial intestinal infections

168

3.29

14.84

1.4

1.5

—

Other bacterial intestinal infections

231

2.91

14.73

1.4

1.5

—

All influenza (not pneumonia)

112

3.86

14.71

2.0

1.4

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

144

683

2.05

14.70

1.4

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.07

14.69

2.9

1.5

—

Neurotic, stress-related and somatoform disorders

228

890

1.79

14.67

1.7

1.5

—

Speech therapy

287

2.69

14.64

1.7

1.4

—

Haemorrhage from respiratory passages

293

2.59

14.50

1.9

1.4

—

Mood disorders, excluding more controls

230

763

1.80

14.49

1.5

—

Emergency coronary revascularization (for ACS)

199

643

1.88

14.48

2.3

1.3

—

Anxiety disorders

229

895

1.79

14.48

1.7

1.4

—

Ischemic heart diseases

195

618

1.90

14.45

2.2

1.3

—

Depression

241

929

1.76

14.44

1.6

1.5

—

Undetermined asthma, excluding more controls

4.66

14.42

1.7

1.1

—

Diseases of arteries, arterioles and capillaries

156

572

2.02

14.42

1.6

1.5

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

189

3.09

14.39

1.1

1.5

—

Other chronic obstructive pulmonary disease, including avohilmo

129

498

2.15

14.32

2.2

1.5

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

22.87

14.29

1.2

3.7

—

Osteoporosis

249

2.75

14.25

1.7

1.3

—

Percutaneous Coronary Intervention

185

592

1.92

14.23

2.3

1.3

—

Rash and other nonspecific skin eruption

102

3.95

14.12

1.5

1.4

—

Pain in joint

146

449

2.08

14.11

1.4

—

GI-bleeding

351

2.49

14.09

1.3

1.5

—

Coronary revascularization (ANGIO or CABG)

184

592

1.91

13.90

2.3

1.3

—

Human immunodeficiency virus [HIV] disease

20.53

13.84

1.2

3.4

—

Abdominal and pelvic pain

246

703

1.76

13.79

1.7

1.5

—

Undetermined asthma

4.47

13.73

1.7

1.1

—

Hypertensive diseases (excluding secondary)

127

338

2.19

13.64

1.6

1.3

—

Atrial fibrillation and flutter

176

2.77

13.55

1.9

1.3

—

Inflammatory diseases of female pelvic organs

156

583

1.97

13.53

1.3

—

Sequelae of external causes of morbidity and mortality

271

2.67

13.47

1.4

1.5

—

Other diseases of the digestive system

347

2.46

13.45

1.3

1.5

—

Bacterial intestinal infections, IBD co-morbidities

184

3.06

13.43

1.4

1.5

—

All-cause Heart Failure

133

450

2.09

13.41

1.6

1.5

—

Syncope and collapse

345

2.36

13.39

1.5

1.4

—

Diseases of the digestive system

119

559

2.12

13.37

1.3

1.5

—

Invasive ventilation

4.60

13.29

1.3

1.7

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

14.00

13.27

2.8

1.9

—

Other disorders involving the immune mechanism, not elsewhere classified

12.32

13.12

2.7

1.8

—

Pneumothorax

4.95

13.10

2.5

1.6

—

Acute myeloid leukaemia

29.54

13.07

2.2

1.0

—

Acute myeloid leukaemia, helper endpoint

29.54

13.07

2.2

1.0

—

Acute myeloid leukaemia, including Hilmo

29.54

13.07

2.2

1.0

—

Varicella [chickenpox]

9.40

12.97

2.0

2.1

—

Purpura and other haemorrhagic conditions

142

3.33

12.96

1.3

1.5

—

Enterocolitis due to Clostridium difficile

3.92

12.95

1.5

1.4

—

Corneal scars and opacities

13.19

12.95

1.4

1.5

—

Major coronary heart disease event

191

629

1.84

12.87

2.3

1.3

—

Immunodeficiency with predominantly antibody defects

9.83

12.77

1.4

1.3

—

Other disorders of white blood cells

5.15

12.69

1.8

1.6

—

Disorders of gallbladder, biliary tract and pancreas

233

857

1.72

12.68

1.6

1.5

—

Disorders of plasma-protein metabolism, not elsewhere classified

25.84

12.63

4.4

1.4

—

Amputation

4.29

12.63

1.2

1.4

—

Mood disorders

248

956

1.68

12.57

1.5

—

Allergic conjunctivitis

149

761

1.91

12.49

1.4

—

Viral conjunctivitis

13.43

12.48

1.2

1.3

—

Disorders of lipoprotein metabolism and other lipidaemias

177

591

1.86

12.47

1.6

1.5

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

154

2.64

12.43

1.7

1.2

—

Mood [affective] disorders

247

956

1.68

12.42

1.5

—

Asthma/COPD (KELA code 203)

228

917

1.71

12.39

1.8

1.4

—

Other anxiety disorders

126

538

2.03

12.36

1.6

1.4

—

Need for immunization against other single viral diseases

14.65

12.32

1.4

1.2

—

Hypertension

186

574

1.83

12.28

1.5

—

Hypertensive diseases

186

575

1.83

12.22

1.5

—

Chronic rhinitis, nasopharyngitis and pharyngitis

382

2.31

12.19

1.4

—

Artificial opening status

6.05

12.13

1.8

1.1

—

Bronchiectasis

4.62

12.11

1.7

1.2

—

Hypoplasia of dental enamel , including avohilmo

5.37

12.10

2.7

2.1

—

Other diseases of lip and oral mucosa

105

493

2.14

12.03

1.5

—

Other and unspecified iridocyclitis

5.70

11.96

1.3

2.3

—

Disturbances of skin sensation

324

2.42

11.95

1.6

1.4

—

Asthma, hospital admissions , main diagnosis only

203

1041

1.72

11.95

1.8

1.4

—

Other infectious diseases

4.42

11.90

1.6

1.7

—

Other and unspecified immunodeficiencies with predominantly antibody defects

15.19

11.89

1.4

1.7

—

Cystitis

196

657

1.78

11.88

1.4

1.5

—

Finngen Rheumatological endpoints

231

776

1.70

11.80

1.3

1.5

—

Acute lymphocytic leukaemia, helper endpoint

31.73

11.78

2.9

1.0

—

Acute lymphocytic leukaemia

31.73

11.78

2.9

1.0

—

Acute lymphocytic leukaemia, including Hilmo

31.73

11.78

2.9

1.0

—

Hypertension, essential

177

549

1.83

11.65

1.5

—

Injuries to the thorax

111

539

2.06

11.64

1.6

1.5

—

Gastro-oesophageal reflux disease

153

712

1.86

11.55

1.9

1.4

—

Anxiety (asthma-related co-morbidities)

151

624

1.87

11.51

1.6

1.4

—

Anterior Iridocyclitis

218

2.72

11.51

1.2

1.5

—

Gingival hyperplasia

5.75

11.49

1.7

2.6

—

Methotrexate

118

3.40

11.48

1.1

—

All anxiety disorders

158

679

1.84

11.45

1.6

1.4

—

Follow-up examination after treatment for conditions other than malignant neoplasms

105

324

2.15

11.27

1.4

1.2

—

Aspergillosis

21.00

11.25

2.5

1.1

—

Adjustment and management of implanted device

151

3.06

11.12

1.6

1.4

—

3.72

11.10

1.3

—

Other systemic involvement of connective tissue (FG)

265

2.50

11.09

1.4

1.5

—

Recurrent or chronic depression

109

368

2.09

11.03

1.8

1.5

—

Use of hypnotics and sedatives

245

863

1.63

10.91

1.6

1.5

—

Viral pneumonia (known virus, not influenza)

8.97

10.80

2.3

2.0

—

Elevated blood glucose level

3.79

10.74

1.8

1.6

—

Preparatory care for dialysis

5.61

10.71

1.2

1.7

—

Autoimmune diseases

259

819

1.61

10.66

1.4

1.6

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

138

745

1.85

10.66

1.3

1.5

—

Used for control exclusion in common control thyroid runs

248

771

1.63

10.62

1.4

1.6

—

Cerebrovascular diseases (FINNGEN)

196

2.50

10.56

1.4

1.3

—

Lichen simplex chronicus and prurigo

4.50

10.48

1.5

1.3

—

Other disorders of eyelid

431

2.10

10.45

1.5

1.4

—

Cardiomyopathy

157

2.94

10.41

1.2

1.5

—

Malignant neoplasm of brain, including Hilmo

5.45

10.40

2.6

1.4

—

Other disorders of penis

3.87

10.37

1.5

1.7

—

Reactive arthropathies, FINNGEN

4.18

10.35

1.7

1.8

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

4.08

10.34

1.6

2.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

300

2.15

10.34

1.8

1.5

—

Malignant neoplasm of eye, brain and central nervous system

8.24

10.32

2.4

1.5

—

Viral pneumonia (unknown virus, not influenza)

4.29

10.30

2.7

1.4

—

Other pleural conditions

3.75

10.29

1.9

1.3

—

Asthma, including avohilmo

276

993

1.56

10.28

1.7

1.5

—

Obesity related asthma

399

2.16

10.24

1.7

1.5

—

Other follicular disorders

4.03

10.22

1.1

1.6

—

Biological medication for rheuma

198

2.69

10.17

1.2

1.6

—

Disorders resulting from impaired renal tubular function

7.97

10.12

1.6

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

123

3.19

10.11

2.0

1.2

—

Other systemic involvement of connective tissue

300

2.34

10.08

1.4

—

Thrombocytopenia, unspecified

4.06

9.95

1.1

1.4

—

Sequelae with surgical and medical care as external cause

212

2.60

9.93

1.4

—

Other and unspecified follicular disorders

7.68

9.90

1.2

2.1

—

Diverticular disease of intestine

149

526

1.81

9.88

1.7

1.5

—

Dermatophytosis

130

3.09

9.88

1.8

1.3

—

Hypoplasia of dental enamel

9.97

9.87

2.8

2.2

—

Glomerulonephritis

100

3.42

9.85

1.1

1.8

—

Persons encountering health services for examination and investigation

143

385

1.86

9.81

1.6

1.3

—

Any mental disorder

250

788

1.59

9.80

1.6

1.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

301

2.08

9.75

1.5

1.3

—

Other disorders of fluid, electrolyte and acid-base balance

307

2.27

9.73

1.5

1.3

—

Other local infections of skin and subcutaneous tissue

106

3.32

9.70

1.7

1.6

—

General examination and investigation of persons without complaint and reported diagnosis

138

385

1.87

9.70

1.8

1.3

—

Pleural effusion

132

3.04

9.63

2.1

1.3

—

Chronic sinusitis

104

530

1.96

9.62

1.9

1.4

—

Other gastritis (incl. Duodenitis)

210

2.58

9.59

2.0

1.3

—

Sulfasalazine

258

2.41

9.55

1.2

1.1

—

Episodal and paroxysmal disorders

258

839

1.57

9.55

1.6

1.5

—

Explicit bacterial Sepsis

3.63

9.52

1.3

1.4

—

Other necrotizing vasculopathies

4.03

9.50

1.3

—

Other cataract

366

2.03

9.45

1.9

1.5

—

Leukaemia of unspecified cell type

22.44

9.42

1.9

1.5

—

Unspecified human immunodeficiency virus [HIV] disease

22.38

9.41

1.2

2.5

—

Heart failure and coronary heart disease

318

2.08

9.38

1.6

1.2

—

Molar incisor enamel hypoplasia, with caries

11.11

9.37

3.3

1.9

—

Cardiovascular diseases

149

446

1.80

9.31

1.6

1.3

—

Non-ischemic cardiomyopathy

266

2.24

9.31

1.5

1.3

—

Other predominantly sexually transmitted diseases, not elsewhere classified

179

2.69

9.28

1.7

1.3

—

Carcinoma in situ of skin

3.83

9.22

2.4

1.3

—

Gingivitis and periodontal diseases

227

734

1.60

9.17

1.6

1.4

—

Melanocytic naevi

352

2.17

9.14

2.0

1.4

—

Other specific joint derangements/joint disorders

175

672

1.68

9.13

1.4

1.6

—

Later onset COPD, excluding more controls

3.30

9.04

1.3

1.1

—

Acute pharyngitis

152

2.82

9.04

1.3

—

Pain (limb, back, neck, head abdominally)

162

467

1.74

8.95

1.6

1.4

—

Secondary hypertension

4.23

8.94

1.2

1.5

—

Neurological diseases, wide definition

173

2.27

8.92

1.7

1.2

—

Polyneuropathies and other disorders of the peripheral nervous system

225

2.45

8.83

1.7

1.6

—

Myeloproliferative diseases

3.61

8.82

1.4

1.3

—

Low back pain

176

764

1.66

8.80

1.5

—

Covid-19 suspected case

262

2.34

8.80

1.7

1.4

—

Scleritis and episcleritis

4.26

8.66

1.2

1.7

—

Drug-induced cataract

8.33

8.60

2.8

1.3

—

Epilepsy

373

2.09

8.60

1.5

—

Other and unspecified tonsillitis

333

2.07

8.59

1.6

1.3

—

Abnormal findings on examination of blood, without diagnosis

102

492

1.91

8.58

1.7

1.6

—

Pure hypercholesterolaemia

148

559

1.73

8.54

1.5

—

Nerve, nerve root and plexus disorders

232

919

1.55

8.54

1.4

1.5

—

Hypothyroidism, drug reimbursement

3.43

8.52

1.5

1.2

—

Streptococcal septicaemia

3.81

8.50

1.3

1.5

—

Cardiac arrhythmias

139

514

1.76

8.50

1.7

1.3

—

Other infectious diseases

3.43

8.48

1.6

—

Other and unspecified local infections of skin and subcutaneous tissue

100

3.22

8.47

1.7

1.6

—

Other predominantly sexually transmitted diseases, not elsewhere classified

230

2.40

8.44

1.6

1.3

—

Other arthritis (FG)

364

2.09

8.42

1.2

1.5

—

Lower back pain or/and sciatica

234

997

1.53

8.40

1.5

—

Functional dyspepsia

293

2.22

8.39

2.0

1.3

—

Other diseases of oesophagus

3.57

8.38

2.3

1.2

—

Other and unspecified disorders of white blood cells

4.91

8.37

2.1

1.6

—

Migraine

121

546

1.80

8.33

1.4

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

8.62

8.32

1.5

1.6

—

Chronic lymphocytic leukaemia, helper endpoint

8.62

8.32

1.5

1.6

—

Chronic lymphocytic leukaemia

8.62

8.32

1.5

1.6

—

Hypothyroidism and >3 levothyroxin purchases

119

2.57

8.32

1.5

1.1

—

Hypothyroidism, levothyroxine purchases

119

2.57

8.32

1.5

1.1

—

Tumor necrosis factor alpha inhibitors

178

2.59

8.31

1.2

1.6

—

Gout, FINNGEN

282

2.23

8.22

1.6

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

3.43

8.21

1.8

1.6

—

Peripheral artery disease

358

1.98

8.19

1.3

1.5

—

Hypothyroidism (congenital or acquired)

120

2.55

8.18

1.5

1.1

—

Hypertensive heart and/or renal disease

174

2.41

8.15

1.2

1.6

—

Speech and linguistic disorders, excluding more controls

3.30

8.15

1.7

—

Senile cataract

129

444

1.78

8.15

1.9

1.5

—

Cellulitis

240

2.34

8.15

1.4

1.5

—

Non-allergic asthma (mode), excluding more controls

117

2.97

8.13

2.6

1.1

—

Phlebitis and thrombophlebitis (not including DVT)

247

2.31

8.09

1.6

1.4

—

Depression or dysthymia

154

501

1.70

8.06

1.6

1.5

—

Statin medication

154

511

1.70

8.06

1.8

1.2

—

Other necrotizing vasculopathies (FG)

4.14

7.99

1.4

—

Carcinoma in situ of skin of other and unspecified parts of face

3.71

7.89

2.3

1.2

—

Gastroduodenal ulcer

237

2.32

7.86

1.5

1.3

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

8.54

7.83

1.1

1.0

—

Multiple myeloma

8.54

7.83

1.1

1.0

—

L01XX Other antineoplastic agents

4.07

7.80

1.6

1.4

—

Urticaria

382

2.02

7.80

1.6

1.4

—

Other skin changes

184

2.51

7.79

2.1

1.4

—

Gout

253

2.20

7.74

1.6

1.8

—

Bullous disorders

3.89

7.70

1.1

1.4

—

Soft tissue disorders

232

786

1.52

7.68

1.5

—

Atopic dermatitis, strict definition with reimbursement

391

1.98

7.63

1.5

—

Other/unspecified reactive arthropathies

3.73

7.62

1.9

1.5

—

Other diseases of upper respiratory tract

243

844

1.50

7.60

1.6

1.5

—

Other specified/unspecified arthritis

319

2.11

7.59

1.2

1.6

—

Dysphagia

248

2.26

7.58

1.5

1.3

—

Reactive arthropathies

3.23

7.51

1.7

1.6

—

Other noninfective gastroenteritis and colitis

301

2.13

7.47

1.5

—

Factors influencing health status and contact with health services

110

2.47

7.45

1.8

1.1

—

Endocrine, nutritional and metabolic diseases

189

605

1.58

7.44

1.8

1.4

—

Other CVD (FINNGEN)

3.27

7.42

2.2

1.1

—

Other disorders of bone

213

2.35

7.41

1.7

1.4

—

Allergic urticaria

3.20

7.38

1.8

1.6

—

Nonischemic cardiomyopathy

3.26

7.36

1.4

1.6

—

Cardiomyopathy (excluding other)

104

2.99

7.33

1.2

1.7

—

Other dialysis

6.89

7.30

1.1

2.4

—

Cardiomyopathies, Primary/intrinsic

3.04

7.30

1.2

1.6

—

Antihypertensive medication - note that there are other indications

147

466

1.67

7.28

1.6

1.3

—

Hypertension, Pulmonary Arterial

16.19

7.28

4.4

1.0

—

Visual disturbances and blindness

118

687

1.72

7.26

1.4

1.5

—

Procreative management

370

1.92

7.25

2.2

1.5

—

Atopic dermatitis

135

663

1.67

7.24

1.4

1.5

—

Impetigo

4.32

7.22

1.1

2.2

—

Other and unspecified corneal deformities and disorders

7.35

7.19

1.4

1.5

—

Mantle cell lymphoma

20.58

7.17

1.2

1.0

—

Other headache syndromes

528

1.82

7.17

1.5

—

Non-allergic asthma (mode)

126

2.76

7.16

2.6

1.1

—

Kela reimbursement Agammaglobulinemia (D80-84)

12.42

7.14

1.5

—

Erythema multiforme

8.01

7.12

1.9

1.4

—

Myelodysplastic syndrome, including Hilmo

7.98

7.11

1.7

1.0

—

Mature T/NK-cell lymphomas, hilmo

12.27

7.11

1.3

—

Mantle cell lymphoma, including Hilmo

12.25

7.11

1.4

1.0

—

Childhood asthma (age<16)

2.97

7.09

1.8

1.1

—

Lung diseases due to external agents

117

2.83

7.09

2.5

1.4

—

Childhood asthma (age<16), excluding more controls

2.97

7.08

1.8

1.1

—

Personal history of other diseases and conditions

134

2.69

7.01

2.1

1.3

—

Malignant neoplasm of brain

7.02

7.00

2.2

1.5

—

Paroxysmal tachycardia

175

2.35

7.00

1.6

1.3

—

Asthma and opportunity respiratory infection

4.39

6.96

2.4

1.4

—

Nonhereditary hypogammaglobulinemia

14.10

6.93

1.5

—

Vocal cord dysfunction

110

2.78

6.92

1.5

1.3

—

Viral hepatitis, IBD co-morbidity

5.46

6.90

1.4

1.3

—

Symptoms and signs involving the urinary system

162

782

1.58

6.90

1.7

1.5

—

Nail disorders

3.12

6.85

2.4

1.6

—

Hodgkin lymphoma, hilmo

6.75

6.82

1.7

1.6

—

Postzoster neuralgia

11.11

6.82

1.2

1.3

—

Fentanyl

3.44

6.81

1.7

1.4

—

Other diseases of intestine

137

2.64

6.78

1.8

1.3

—

Migraine without aura

235

2.22

6.76

1.6

1.4

—

Peripheral artery operations in Hilmo

3.02

6.75

1.2

1.3

—

L02BA Anti-estrogens

173

2.44

6.73

1.0

1.3

—

Hypertensive Heart Disease

161

2.34

6.72

1.2

1.6

—

Other diseases of anus and rectum

334

2.01

6.72

1.4

—

Visual disturbances

109

636

1.72

6.71

1.4

1.5

—

Personal history of malignant neoplasm

3.40

6.69

2.3

1.1

—

Diseases of the musculoskeletal system and connective tissue

128

378

1.70

6.66

1.6

1.5

—

Neurological diseases

193

633

1.53

6.66

1.7

1.5

—

Atherosclerosis, excluding cerebral and coronary sclerosis

333

1.91

6.65

1.3

1.5

—

Seropositive rheumatoid arthritis

255

2.15

6.65

1.1

1.5

—

Iron deficiency anaemia

512

1.79

6.63

1.5

1.4

—

Episcleritis

4.03

6.62

1.2

1.8

—

Suppurative and necrotic conditions of lower respiratory tract

4.02

6.62

1.2

1.7

—

Diaphragmatic hernia

393

1.91

6.57

1.6

1.4

—

STROKE

107

417

1.75

6.56

1.4

1.2

—

Noninfective enteritis and colitis

108

632

1.71

6.55

1.4

1.5

—

Aortic aneurysm

190

2.33

6.53

1.8

1.5

—

Entropion and trichiasis of eyelid

3.65

6.46

1.5

1.1

—

Seropositive rheumatoid arthritis, strict definition

153

2.49

6.41

1.1

1.5

—

Iron deficiency anaemia secondary to blood loss (chronic)

159

2.46

6.41

1.4

1.3

—

Migraine with aura and triptan purchases

190

2.32

6.38

1.4

1.5

—

Depression medications

126

2.24

6.34

1.5

1.1

—

Bacterial, viral and other infectious agents

3.04

6.34

1.9

2.0

—

Respiratory disorders in diseases classified elsewhere

9.42

6.32

2.3

1.2

—

Behçet disease

+∞

6.30

1.8

0.0

—

Other complications of surgical and medical care, not elsewhere classified

2.90

6.30

2.2

1.5

—

Subjective visual disturbances

282

2.06

6.29

1.5

1.4

—

Viral and other specified intestinal infections

337

1.95

6.29

1.4

1.5

—

Diseases of the ear and mastoid process

256

900

1.43

6.29

1.5

—

Noninfectious colitis NAS

155

2.46

6.25

1.4

1.6

—

Fall on same level

253

970

1.43

6.23

1.4

1.5

—

Rheumatoid arthritis

332

1.92

6.22

1.1

1.6

—

Abnormalities of heart beat

365

1.91

6.21

1.7

1.3

—

Chronic pancreatitis

126

2.63

6.21

2.0

1.3

—

Hyperlipidaemia, other/unspecified

374

1.87

6.20

1.6

1.4

—

Dermatitis due to substances taken internally

3.68

6.20

1.6

1.7

—

Other neurological diseases

146

730

1.57

6.19

1.5

1.6

—

Chronic periodontitis, including avohilmo

198

897

1.48

6.19

1.8

1.4

—

Acute pancreatitis

193

2.29

6.17

1.4

—

Selective serotonin reuptake inhibitors

216

769

1.47

6.15

1.4

1.5

—

Dorsalgia

216

790

1.47

6.15

1.7

1.5

—

Viral and other specified intestinal infections

258

2.09

6.14

1.5

1.6

—

Benign neoplasms

215

811

1.46

6.09

1.7

1.4

—

Bacterial, viral and other infectious agents

2.84

6.09

1.9

—

Budesonide

116

2.68

6.07

1.4

1.1

—

Periodontitis

198

899

1.47

6.06

1.8

1.4

—

Superficial injury of head

266

2.07

6.06

1.2

1.5

—

Myalgia

273

2.06

6.05

1.4

1.5

—

Malignant neoplasm of skin

315

1.83

6.05

1.7

1.6

—

Hernia of abdominal wall, postoperative

105

2.77

6.03

1.4

1.2

—

Intestinal stricture

349

1.92

6.01

1.5

—

Presence of cardiac and vascular implants and grafts

312

1.86

6.01

1.5

1.2

—

Other and unspecified glaucoma

3.35

5.99

1.2

1.3

—

Hyperkalaemia

3.88

5.98

1.8

1.2

—

Malignant neoplasm of bronchus and lung, including Hilmo

146

2.36

5.95

1.4

—

Gastric ulcer

159

2.40

5.93

1.6

1.2

—

In situ neoplasms

437

1.81

5.89

1.9

1.3

—

Nutritional anaemias

100

570

1.69

5.88

1.6

1.4

—

6-mercaptopurine

6.41

5.86

1.6

2.3

—

Disorders of eyelid in diseases classified elsewhere

5.82

5.84

1.0

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

195

851

1.47

5.83

1.5

—

Pulmonary eosinophilia, not elsewhere classified

11.33

5.82

1.5

1.1

—

Heart failure and bmi 25plus

252

1.91

5.78

1.5

—

Valvular operations

125

2.57

5.77

1.2

1.7

—

Diplopia

131

2.53

5.77

1.4

1.5

—

Diabetic nephropathy, excluding more controls

101

2.61

5.74

1.3

2.0

—

Cardiomyopathy, other and unspecified

3.24

5.72

1.3

1.5

—

Disorder of external ear, unspecified

5.21

5.71

1.1

1.6

—

D07AA Corticosteroids, weak (group I)

206

2.19

5.71

1.3

1.6

—

Persons with potential health hazards related to communicable diseases

540

1.71

5.71

1.6

1.5

—

Other specified and unspecified disorders of eye and adnexa

5.20

5.70

1.1

1.6

—

Malignant neoplasm of mesothelium and soft tissue

6.13

5.69

1.1

—

Other external causes of accidental injury

177

590

1.50

5.67

1.5

1.6

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

200

942

1.45

5.65

1.5

—

Superficial injury of lower leg

301

1.96

5.65

1.5

1.4

—

Routine general health check-up of defined subpopulation

7.58

5.64

2.5

1.1

—

Paralytic ileus and intestinal obstruction

274

2.01

5.62

1.5

1.4

—

Fracture of rib(s), sternum and thoracic spine

330

1.91

5.59

1.8

1.5

—

Erythema nodosum

5.06

5.57

2.0

1.3

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

5.04

5.56

1.9

—

Personality disorders, excluding more controls

282

1.99

5.56

1.3

1.4

—

Ulcerative colitis, NAS

158

2.35

5.55

1.4

1.5

—

Cardiodefibrillation

380

1.84

5.53

1.7

1.6

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

276

2.00

5.53

1.1

1.5

—

Disorders of other endocrine glands

578

1.67

5.52

1.8

1.4

—

Malignant neoplasm, without specification of site, including Hilmo

5.86

5.52

1.0

1.5

—

Other antidepressants

214

763

1.44

5.52

1.5

—

External causes of morbidity and mortality

141

450

1.57

5.50

1.5

1.6

—

Malignant neoplasm of breast, ER-positive, including Hilmo

236

1.96

5.49

1.1

1.4

—

Haemolytic anaemias

4.64

5.49

2.5

1.4

—

Dilated cardiomyopathy

111

2.62

5.46

1.2

1.6

—

Other specified/unspecified systemic involvement of connective tissue

3.35

5.44

2.1

1.2

—

Amputation of toe

3.35

5.44

1.2

1.4

—

Chronic myeloid leukaemia, including Hilmo

16.33

5.43

1.4

1.0

—

Dermatophytosis

126

807

1.56

5.43

1.5

—

Diseases of liver

398

1.81

5.42

1.6

1.5

—

Malignant neoplasm of respiratory system and intrathoracic organs

136

2.33

5.41

1.1

1.4

—

Ulcer of vagina/vulva

5.23

5.40

1.4

—

Panic disorder

160

2.32

5.40

1.4

—

Prurigo nodularis

6.26

5.39

2.0

1.4

—

Localized swelling, mass and lump of skin and subcutaneous tissue

363

1.85

5.38

1.5

—

Etanercept

3.10

5.34

1.3

1.7

—

Need for other prophylactic measures

3.29

5.30

1.2

1.9

—

Other diseases of pericardium

4.74

5.30

1.8

1.7

—

Other or unspecified ileus, impaction or obstruction

174

2.25

5.30

1.6

1.4

—

Migraine without aura and triptan purchases

207

2.13

5.26

1.6

1.4

—

Chronic nephritic syndrome

5.04

5.25

1.1

1.7

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

285

1.81

5.24

1.6

1.5

—

Hereditary hypogammaglobulinemia

+∞

5.24

1.0

0.0

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

5.42

5.22

1.4

1.5

—

Mucosal proctocolitis

138

2.40

5.20

1.2

1.5

—

Injuries to the knee and lower leg

251

1012

1.38

5.19

1.5

—

Disorders of synovium and tendon

108

589

1.61

5.19

1.5

—

Other/unspecified seropositive rheumatoid arthritis

283

1.95

5.18

1.1

1.5

—

Collagenous colitis

2.69

5.16

1.6

1.5

—

Wegener granulomatosis

7.45

5.16

1.6

1.3

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

473

1.72

5.16

1.4

—

Missing teeth due to accident, extraction or parodontitis

115

688

1.58

5.15

1.7

1.5

—

Malignant neoplasm of breast, HER-positive

234

1.94

5.13

1.1

1.4

—

Atopic dermatitis, strict definition

418

1.76

5.13

1.5

—

5-aminosalicylic acid

183

2.19

5.13

1.3

1.2

—

Hypokalaemia

109

2.58

5.12

1.2

—

Other and unspecified polyneuropathies, also in other diseases

190

2.16

5.10

1.8

1.4

—

Diseases of middle ear and mastoid

129

686

1.54

5.10

1.6

1.5

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

13.61

5.10

1.4

1.2

—

Diseases of male genital organs

106

324

1.65

5.10

1.8

1.7

—

Other benign neoplasms of skin

443

1.74

5.09

1.9

1.4

—

Insulin, combination of fast acting with intermediate-acting or long-acting

122

719

1.55

5.09

1.7

1.6

—

5.72

5.07

2.2

1.2

—

Falls/tendency to fall

233

838

1.39

5.07

1.5

1.6

—

Psychiatric diseases

206

725

1.42

5.07

1.6

1.5

—

Pericarditis

5.69

5.06

2.5

1.6

—

Speech and linguistic disorders

122

2.45

5.06

1.7

1.8

—

Seropositive rheumatoid arthritis, wide

286

1.93

5.03

1.1

1.5

—

Migraine with aura

293

1.91

5.03

1.3

1.4

—

Sequelae of other external causes

3.42

5.02

1.5

1.4

—

Otitis media, unspecified

129

2.36

4.97

2.2

1.7

—

Other Crohn's disease

3.04

4.94

1.1

1.6

—

SLE (Finngen)

4.36

4.94

1.8

1.6

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

104

634

1.60

4.93

1.9

1.5

—

Polyuria

233

2.02

4.93

1.9

1.5

—

Nummular dermatitis

2.87

4.92

1.9

1.4

—

Inflammatory diseases of the central nervous system

2.87

4.92

1.9

1.5

—

Nonorganic sleeping disorders, excluding more controls

200

2.10

4.90

1.1

1.4

—

Atrial fibrillation and flutter with reimbursement

131

2.14

4.88

1.7

1.3

—

Iridocyclitis in diseases classified elsewhere

7.78

4.86

1.1

1.5

—

Sicca syndrome [Sjögren]

2.71

4.84

1.2

1.3

—

Systemic lupus erythematosus

4.25

4.82

1.8

1.2

—

Malignant neoplasm of bone and articular cartilage

11.66

4.80

1.1

1.0

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

11.65

4.80

1.1

1.0

—

Somnolence

11.59

4.80

1.4

—

Drug-induced osteoporosis with pathological fracture

6.57

4.79

1.8

1.2

—

Other and unspecified drugs and medicaments

2.75

4.77

1.9

1.5

—

Gout, unspecified

189

2.12

4.77

1.6

—

Acute pancreatitis (for exclusion)

216

2.04

4.75

1.4

1.6

—

Follicular cysts of skin and subcutaneous tissue

196

2.10

4.74

1.2

1.5

—

Impotence

4.44

4.74

2.7

1.9

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

2.62

4.72

1.6

1.4

—

Myeloproliferative diseases (CML excluded)

2.95

4.71

1.5

1.3

—

Viral infections of the central nervous system

2.95

4.71

1.4

1.6

—

Non-rheumatic valve diseases

377

1.67

4.70

1.6

—

Valvular heart disease excluding rheumatic fever

383

1.66

4.69

1.6

—

Rheumatoid arthritis, including avohilmo

447

1.70

4.68

1.1

1.4

—

Malignant neoplasm of head and neck

3.03

4.66

1.6

1.4

—

Other superficial mycoses

7.22

4.66

3.4

2.3

—

Disorders of parathyroid gland

215

2.03

4.65

1.4

—

Other dorsopathies, not elsewhere classified

211

794

1.39

4.64

1.6

1.5

—

Dislocation, sprain and strain of joints and ligaments of thorax

5.04

4.63

1.5

2.1

—

Haemorrhage, not elsewhere classified

5.03

4.63

1.5

—

Congenital malformations, deformations and chromosomal abnormalities

127

806

1.50

4.62

1.5

—

Volume depletion

2.76

4.60

1.6

1.4

—

Drug-induced systemic lupus erythematosus

14.35

4.60

1.1

1.6

—

Pneumonia due to Streptococcus pneumoniae

5.48

4.60

1.2

—

Eosinophilic disease (BM)

14.14

4.58

1.3

1.0

—

Personal history of medical treatment

8.34

4.58

1.6

1.1

—

Other embolism and thrombosis

134

2.32

4.58

1.4

—

Ulcerative colitis

289

1.87

4.57

1.4

1.5

—

Ischaemic heart disease, wide definition

145

609

1.48

4.54

1.8

1.5

—

Allergic rhinitis

424

1.71

4.52

1.6

1.5

—

Other symptoms and signs involving cognitive functions and awareness

479

1.64

4.52

1.3

1.5

—

Inflammatory disease of uterus

154

2.21

4.51

1.4

1.3

—

Nephrotic syndrome

4.86

4.50

1.0

2.3

—

Hypersensitivity pneumonitis due to organic dust

6.76

4.48

3.9

1.4

—

Malignant neoplasm of bronchus and lung

121

2.27

4.48

1.1

1.4

—

Viral encephalitis, not elsewhere classified/unspecified

6.74

4.48

1.4

1.3

—

Chronic viral hepatitis

3.28

4.47

1.1

1.9

—

Disorders of tooth development and eruption

155

2.09

4.45

1.5

1.4

—

Melanocytic naevi of trunk

136

2.29

4.44

2.1

1.4

—

Accidents

169

590

1.44

4.41

1.6

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

182

2.09

4.40

1.1

1.4

—

Cholangitis (primary sclerosing, PSC)

3.01

4.39

1.3

1.5

—

Other diseases of blood and blood-forming organs

3.01

4.39

1.8

1.6

—

Benign neoplasm: Colon

604

1.57

4.39

1.6

1.5

—

Other/unspecified dorsalgia

482

1.65

4.38

1.8

1.5

—

Benign neoplasm of colon, rectum, anus and anal canal

117

672

1.51

4.38

1.6

1.5

—

Other and unspecified vascular occlusions

2.83

4.38

1.4

1.3

—

Ptosis of eyelid

106

2.46

4.37

1.5

1.2

—

Cramp and spasm

3.35

4.32

1.3

1.5

—

Ulcerative ileocolitis

4.27

4.32

1.4

2.0

—

Actinic keratosis

374

1.71

4.30

2.1

1.3

—

Microscopic polyangiitis

12.01

4.30

1.0

1.5

—

Sarcoidosis

138

2.25

4.30

2.1

1.5

—

Injuries to unspecified part of trunk, limb or body region

113

2.40

4.30

1.7

—

Pemphigus

11.95

4.30

1.1

1.5

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

286

1.70

4.30

1.1

1.4

—

Malignant neoplasm of breast, including Hilmo

286

1.70

4.30

1.1

1.4

—

Urethral stricture

3.96

4.29

2.1

1.5

—

Irregular menses

102

518

1.56

4.29

1.5

1.3

—

Malignant neoplasm of oropharynx

11.79

4.28

1.9

1.0

—

Other viral hepatitis

2.96

4.28

1.4

1.8

—

Insulin medication

122

689

1.49

4.25

1.7

1.5

—

Skin changes due to chronic exposure to nonionizing radiation

381

1.70

4.25

2.1

1.3

—

Exposure to other specified factors

156

1011

1.42

4.23

1.5

—

Diseases of oral cavity, salivary glands and jaws

109

361

1.55

4.20

1.6

1.4

—

Disorders of thyroid, IBD co-morbidities

113

2.18

4.20

1.9

1.2

—

Caries of enamel

185

966

1.38

4.20

1.5

—

Arterial embolism and thrombosis

3.86

4.19

1.3

1.4

—

Other and unspecified urticaria

234

1.93

4.18

1.2

1.5

—

Osteonecrosis due to drugs

7.03

4.18

3.4

1.2

—

Guillain-Barre syndrome

7.01

4.17

1.3

1.2

—

Viral infections of the central nervous system

2.91

4.17

1.4

1.6

—

Congenital malformations, deformations and chromosomal abnormalities

138

881

1.44

4.16

1.6

1.5

—

Carcinoma in situ of skin of scalp and neck

5.29

4.15

2.0

1.1

—

Acquired haemolytic anaemia

5.29

4.15

1.7

1.1

—

Other encephalitis

5.28

4.15

2.0

1.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

101

653

1.54

4.14

1.6

1.5

—

Gout, strict definition

160

2.13

4.14

1.4

1.6

—

Hypotension

160

2.13

4.13

2.0

1.4

—

Symptoms and signs concerning food and fluid intake

2.66

4.13

1.7

1.2

—

Systemic lupus erythematosus, unspecified

4.37

4.13

1.8

1.3

—

Acute peritonitis

3.00

4.12

1.2

1.5

—

Other CVD

201

1.99

4.10

1.9

1.4

—

Gout, idiopatic and unspecified

243

1.90

4.09

1.6

1.5

—

Decubitus ulcer and pressure area

3.09

4.08

1.4

1.3

—

Diseases of tongue

3.09

4.08

1.2

1.3

—

Other and unspecified bullous disorders

8.14

4.08

1.0

1.3

—

Secondary thrombocytopenia

8.12

4.07

1.0

1.3

—

Pruritus

110

2.37

4.06

1.6

1.5

—

Acute generalized exanthematous pustulosis

3.21

4.06

1.7

1.5

—

Coronary atherosclerosis

111

463

1.52

4.04

1.8

1.3

—

Early syphilis

10.11

4.02

3.0

1.4

—

406

1.65

4.01

2.1

1.3

—

Inflammatory bowel disease

414

1.67

4.01

1.3

1.5

—

Idiopathic thrombocytopenic purpura

5.04

4.01

1.0

1.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

301

1.79

4.01

1.3

—

Other surgical follow-up care

5.03

4.00

1.0

1.4

—

Injury, poisoning and certain other consequences of external causes

110

360

1.53

3.99

1.5

1.6

—

Keratoconus

6.48

3.99

1.2

2.2

—

Syphilis

6.48

3.99

2.4

1.9

—

Syphilis

6.48

3.99

2.4

1.9

—

Malignant neoplasm of other connective and soft tissue

5.60

3.98

1.2

—

Short stature, not elsewhere classified

3.36

3.97

3.4

2.1

—

Rosacea

124

2.27

3.96

2.1

1.4

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

2.53

3.93

1.9

1.3

—

Congenital malformations of the circulatory system

178

2.02

3.93

2.0

1.7

—

Vasomotor and allergic rhinitis

500

1.59

3.91

1.6

1.5

—

SLE, ICD10

3.81

3.90

1.8

1.3

—

SLE, strict definition

3.81

3.90

1.8

1.3

—

Follicular lymphoma, hilmo

3.81

3.89

1.2

1.5

—

Concussion

102

549

1.52

3.89

1.2

1.5

—

Mixed connective tissue disease

2.78

3.85

2.1

1.2

—

Hernia

182

893

1.37

3.85

1.5

—

Diabetic nephropathy

150

2.11

3.82

1.3

1.7

—

conjunctival haemorrhage

2.69

3.82

1.3

—

All dysplastic lesions of the vulva

3.08

3.81

1.7

1.3

—

Adalimumab

101

2.38

3.81

1.1

1.7

—

Shoulder lesions

137

578

1.44

3.80

1.5

—

Constipation

176

890

1.37

3.79

1.4

1.6

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

3.96

3.79

1.3

1.4

—

Arthropathies

188

697

1.37

3.79

1.3

1.6

—

ILD medications: nintedanib

12.32

3.79

5.3

1.0

—

Malignant neoplasm of testis, including Hilmo

8.82

3.78

1.0

2.4

—

Lesion of lateral popliteal nerve

3.20

3.77

2.2

1.5

—

Dependence on enabling machines and devices, not elsewhere classified

8.83

3.77

1.0

2.6

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

180

2.00

3.77

1.3

1.5

—

Persistent mood disorders

201

1.94

3.75

1.3

—

Fenamates

119

2.06

3.75

1.3

1.6

—

Osteomyelitis

2.92

3.73

1.8

1.4

—

Papulosquamous disorders

493

1.58

3.72

1.2

1.5

—

Carcinoma in situ of skin of trunk

4.17

3.71

1.2

—

Adverse effects, not elsewhere classified

252

1.83

3.69

1.6

—

Scleritis

6.76

3.68

1.1

1.5

—

Dizziness and giddiness

142

801

1.41

3.67

1.5

—

Peripheral arterial reconstruction

148

2.10

3.67

1.3

1.4

—

Irritable bowel syndrome

326

1.72

3.67

1.2

1.3

—

Disorders of oesophagus in diseases classified elsewhere

5.68

3.66

2.1

1.2

—

Acute nephritic syndrome

5.68

3.66

1.0

1.3

—

Suppurative and unspecified otitis media

444

1.58

3.65

1.9

1.4

—

Fall on and from stairs and steps

290

1.76

3.63

1.3

1.6

—

Carcinoma in situ of skin of upper limb, including shoulder

4.44

3.63

1.3

1.2

—

Encephalitis

4.43

3.62

2.0

1.4

—

Infectious mononucleosis

2.48

3.62

1.4

1.7

—

Malignant neoplasm of breast

283

1.64

3.62

1.1

1.4

—

Attention to artificial openings

4.02

3.59

1.7

1.2

—

Other or ill-defined heart diseases

3.73

3.59

1.2

1.8

—

Phobic anxiety disorders

136

2.13

3.58

1.3

1.4

—

Osteoporosis with pathological fracture (FG)

2.75

3.58

1.6

1.2

—

Other bacterial agents as the cause of diseases classified to other chapters

7.90

3.57

1.6

2.4

—

Infection due to other mycobacteria

7.85

3.56

3.3

1.0

—

Ulcerative colitis (strict definition, require KELA)

184

1.96

3.56

1.3

1.5

—

Polycythaemia vera

4.79

3.56

1.7

1.6

—

Injuries to the head

223

1047

1.31

3.54

1.3

1.6

—

Other disorders of kidney and ureter

124

2.18

3.53

1.5

1.4

—

Substance use, excluding alcohol

227

1.85

3.53

1.7

1.5

—

Cholelithiasis, broad definition with cholecystitis

162

796

1.37

3.53

1.6

1.5

—

Malignant neoplasm of breast, HER2-negative

276

1.64

3.52

1.1

1.4

—

Atrophic disorders of skin

144

2.09

3.52

1.3

—

Other and unspecified acquired haemolytic anaemias

10.15

3.51

1.8

1.3

—

Other endocrine disorders

2.58

3.51

2.9

1.9

—

Intracranial and intraspinal abscess and granuloma

10.12

3.50

2.0

1.5

—

Early syphilis

10.11

3.50

3.2

1.5

—

IgA nephropathy (IgA glomerulonephritis)

6.20

3.50

1.3

2.0

—

Thoracic aortic aneurysm

131

2.14

3.50

2.0

1.5

—

Diseases of salivary glands

377

1.65

3.48

1.5

—

Rotator cuff syndrome

108

529

1.47

3.46

1.4

1.5

—

Viral hepatitis

2.54

3.46

1.4

1.7

—

Injury of unspecified body region

2.54

3.46

1.6

1.9

—

Anomalies of dental arch relationship, including avohilmo

232

1.79

3.42

2.6

1.5

—

Nasal polyp

201

1.89

3.42

1.9

1.3

—

Triptan medication for migraine, min. 3 purchases

114

603

1.44

3.42

1.5

1.4

—

Crohn disease

146

2.06

3.41

1.2

1.5

—

Medicines for HER+ breast cancer

396

1.61

3.38

1.1

1.4

—

Other and unspecified iron deficiency

403

1.61

3.38

1.6

1.4

—

Drug-induced polyneuropathy

7.13

3.38

2.1

2.9

—

Other congenital malformations

160

2.00

3.38

2.1

1.8

—

Malignant immunoproliferative diseases

7.12

3.38

1.0

1.3

—

Other and unspecified nail disorders

5.04

3.37

3.3

1.4

—

Other and unspecified aplastic anaemias

7.10

3.37

1.6

1.1

—

Isolated proteinuria

5.03

3.37

1.1

1.4

—

Brain glioblastoma and astrocytoma

7.06

3.37

1.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

147

2.05

3.35

1.9

1.4

—

Benzodiazepine use

197

1030

1.32

3.34

1.4

1.5

—

All dysplastic lesions of the cervix uteri, vagina or vulva

368

1.64

3.34

1.3

1.4

—

Hypoplasia of dental enamel, prenatal

9.25

3.33

1.5

3.7

—

Transient ischemic attack

492

1.50

3.32

1.4

1.5

—

Personality disorders

336

1.67

3.32

1.3

1.5

—

Focal epilepsy

239

1.80

3.32

1.5

1.6

—

Disorders of calcium metabolism

2.72

3.32

1.6

1.3

—

Melanocytic naevi, other sites/unspecified

2.42

3.30

2.4

1.5

—

Fibrosis and cirrhosis of liver

2.48

3.29

1.6

1.4

—

Other inflammation of vagina/vulva

3.66

3.29

1.2

1.4

—

Other noninflammatory disorders of vulva and perineum

102

2.26

3.28

1.2

1.4

—

Colonic or urogenital fistula

307

1.70

3.28

1.7

1.4

—

Injuries to the ankle and foot

145

943

1.37

3.28

1.5

—

Osteopathy in diseases classified elsewhere

8.74

3.28

1.0

1.4

—

Pyoderma gangrenosum

8.72

3.28

1.7

1.3

—

Gout due to impairment of renal function

8.68

3.27

1.0

1.4

—

Other prurigo

8.67

3.27

1.0

1.4

—

Fissure and fistula of anal and rectal regions

270

1.74

3.27

1.7

1.4

—

Acute suppurative otitis media

336

1.64

3.25

2.1

1.5

—

Unknown and unspecified causes of morbidity

2.79

3.25

1.4

1.3

—

Inflammatory bowel disease, strict (require KELA)

278

1.73

3.24

1.3

1.5

—

Poisoning by drugs, medicaments and biological substances

293

1.71

3.24

1.3

1.5

—

Seborrhoeic dermatitis

2.34

3.24

2.0

1.5

—

Somatoform disorder

170

1.95

3.22

1.2

1.3

—

Focal epilepsy, strict definition

220

1.82

3.21

1.6

—

Crohn's disease NAS

2.59

3.21

1.1

1.8

—

Other joint disorders

175

689

1.34

3.20

1.3

1.6

—

Malignant melanoma, including Hilmo

143

2.03

3.20

1.4

—

Total colectomy operation

3.55

3.20

1.6

—

Total colectomy

3.55

3.20

1.6

—

Endocarditis

4.19

3.19

1.2

1.8

—

Unspecified nephritic syndrome

5.37

3.19

1.1

1.2

—

Chronic myeloproliferative disease

6.44

3.19

1.6

1.3

—

Other specified and unspecified disorders of eyelid

6.43

3.19

1.0

1.3

—

Other arterial embolism and thrombosis

5.36

3.19

1.0

1.3

—

Atypical facial pain

2.87

3.19

1.4

—

Chronic apical periodontitis

220

969

1.29

3.19

1.4

1.5

—

Substance abuse, excluding more controls

580

1.46

3.18

1.6

1.5

—

Other functional intestinal disorders

512

1.51

3.18

1.4

—

Asthma mixed form (mode)

3.80

3.18

1.1

—

Asthma mixed form (mode), excluding more controls

3.80

3.18

1.1

—

LSIL lesion of the cervix uteri, vagina or vulva

164

1.96

3.18

1.3

—

Strabismus

332

1.66

3.17

1.4

1.5

—

Congenital malformations and deformations of the musculoskeletal system

116

2.15

3.17

1.6

2.0

—

Deep bite

131

2.01

3.15

1.9

1.8

—

Ingrowing nail

2.74

3.15

2.5

1.8

—

Amiodarone users

2.36

3.14

1.5

—

IBD patients in KELA-register

281

1.71

3.14

1.3

1.5

—

Non-small cell lung cancer, including Hilmo

110

2.14

3.13

1.6

1.4

—

Other specified/unspecified bacterial intestinal infections

2.63

3.13

1.3

1.5

—

Chronic ulcer of skin, not elsewhere classified

2.63

3.13

1.4

—

Other and unspecified mood [affective] disorders

2.55

3.12

1.6

1.4

—

Amyloidosis

4.54

3.12

1.1

1.2

—

Other congenital malformations

111

2.17

3.11

2.0

—

Other arrhythmias

113

602

1.42

3.10

1.7

1.5

—

Voice disturbances

305

1.67

3.09

1.3

1.5

—

Other diseases of liver

187

1.88

3.09

1.6

1.5

—

Pemphigoid

4.03

3.09

1.2

—

Retinal vascular occlusion

105

2.20

3.08

1.4

1.3

—

Retinal vascular disorders

105

2.20

3.08

1.4

1.3

—

Presence of other functional implants

399

1.50

3.07

1.7

1.1

—

Disorders of psychological development

160

1.92

3.07

2.1

1.7

—

Symptoms and signs involving speech and voice

375

1.60

3.06

1.3

1.5

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

7.60

3.06

1.3

1.4

—

Operations for atrial fibrillation

7.57

3.06

1.2

2.3

—

Malignant neoplasm of testis

7.56

3.06

1.0

2.4

—

Malignant neoplasm of digestive organs

257

1.66

3.06

1.4

1.6

—

Abnormal findings on examination of urine, without diagnosis

3.19

3.05

2.0

1.5

—

Other disorders of conjunctiva

146

1.99

3.04

1.4

—

Hypersomnia

5.89

3.03

1.0

1.3

—

Portal vein thrombosis

5.89

3.03

1.4

1.5

—

Other and unspecified coagulation defects

2.90

3.02

1.7

1.5

—

Pulmonary oedema

5.87

3.02

1.1

—

Neovascular glaucoma

3.35

3.02

1.4

1.6

—

Glaucoma secondary to other eye disorders

3.35

3.02

1.4

1.5

—

Spondylosis

534

1.45

3.01

1.5

—

Amenorrhoea

2.31

3.00

1.8

1.3

—

Other and unspecified rosacea

2.31

3.00

2.5

1.4

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

218

1.79

3.00

1.1

1.4

—

Malignant neoplasm of small intestine, including Hilmo

4.31

2.99

1.8

1.6

—

Vertical strabismus

3.57

2.99

1.0

1.7

—

Other corneal oedema

10.14

2.99

1.2

1.4

—

Misadventures to patients during surgical and medical care

147

1.98

2.99

1.3

1.4

—

Hypo-osmolality and hyponatraemia

174

1.89

2.98

1.6

1.3

—

Exfoliative dermatitis

10.10

2.98

1.0

1.2

—

Hereditary corneal dystrophies

3.87

2.98

1.3

1.4

—

Other symptoms and signs involving the circulatory and respiratory systems

2.75

2.98

2.3

1.4

—

Disorders of choroid and retina

144

758

1.35

2.96

1.5

1.6

—

Other sleep disorders

107

2.15

2.96

2.0

1.3

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

2.55

2.95

1.4

1.7

—

Chondropathies

176

1.88

2.94

2.1

1.5

—

Disorders of adult personality and behaviour

364

1.60

2.93

1.3

1.5

—

Bullous pemphigoid

4.74

2.92

1.3

1.2

—

Retention of urine

297

1.60

2.91

1.2

1.6

—

Other intervertebral disc disorders

155

699

1.34

2.89

1.6

1.4

—

Other and unspecified diseases of blood and blood-forming organs

4.12

2.88

1.6

1.5

—

Drug-induced osteoporosis

5.45

2.88

3.1

1.3

—

Acquired absence of organs, not elsewhere classified

6.74

2.87

1.7

1.1

—

Malignant neoplasm of oropharynx, including Hilmo

5.42

2.87

1.9

1.0

—

Other disorders of optic [2nd] nerve and visual pathways

2.51

2.87

2.6

1.7

—

Behavioural disorders, excluding more controls

5.40

2.86

1.0

2.0

—

Other obstructive and reflux uropathy

3.17

2.85

1.2

1.4

—

Open wound of lower leg

164

1.89

2.84

1.2

1.4

—

Superficial injury of hip and thigh

136

1.99

2.84

1.7

1.4

—

Other puerperal infections

2.30

2.84

1.1

1.4

—

Hypoplasia of dental enamel, prenatal , including avohilmo

4.61

2.83

1.4

2.9

—

Other noninfective disorders of lymphatic vessels and lymph nodes

3.35

2.81

1.8

1.6

—

Hypertrophic cardiomyopathy

3.35

2.81

1.0

1.5

—

Myocarditis

3.34

2.81

1.2

1.4

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

201

1.79

2.80

1.3

1.4

—

Other disorders of prostate

4.46

2.79

1.4

1.7

—

Acute lymphadenitis

2.65

2.79

1.4

1.9

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

158

1.90

2.79

1.3

1.4

—

L04AC Interleukin inhibitors

2.55

2.78

1.3

1.6

—

Other maltreatment syndromes

3.59

2.78

1.0

2.2

—

Juvenile osteochondrosis

3.59

2.78

3.2

1.6

—

Cutaneous lupus erythematosus

3.94

2.78

1.1

1.3

—

Systemic sclerosis

3.94

2.78

2.3

1.3

—

Sciatica+with lumbago

623

1.42

2.77

1.5

—

Chronic iridocyclitis

3.09

2.77

1.1

1.9

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

209

1.77

2.77

1.6

—

Hyperparathyroidism

185

1.82

2.76

1.2

1.4

—

Other superficial mycoses

2.17

2.76

2.2

1.4

—

Colitis, primary sclerosing, strict definition

8.42

2.75

1.0

1.3

—

Malignant neoplasm of tonsil

8.40

2.75

2.0

1.0

—

Cholelithiasis

150

780

1.33

2.75

1.6

1.5

—

Intracranial trauma

111

562

1.39

2.74

1.2

1.5

—

Marginal zone B-cell lymphoma, including Hilmo

5.05

2.73

1.1

1.2

—

Eosinophilia

5.05

2.73

1.3

2.0

—

LSIL lesion of the vulva

3.26

2.73

1.9

1.4

—

Other congenital malformations of skin

2.72

1.8

1.7

—

Poisoning by medicine

263

1.68

2.71

1.3

1.5

—

Spondylopathies

141

629

1.34

2.71

1.6

1.5

—

Other papulosquamous disorders

6.07

2.70

1.2

—

Malignant cancer of tonsil and base of tongue

6.04

2.70

2.0

1.0

—

Tubulo-interstitial nephritis, not specified as acute or chronic

2.51

2.70

2.3

1.5

—

Respiratory conditions due to other external agents

4.24

2.68

1.3

1.4

—

Basal cell carcinoma, including avohilmo

286

1.54

2.68

1.7

1.5

—

Hypertensive Renal Disease

4.23

2.68

1.0

—

Systemic sclerosis, icd10

3.78

2.67

2.3

1.4

—

Nonorganic sleeping disorders

249

1.69

2.67

1.1

1.5

—

Outcome of delivery

132

1.78

2.67

1.3

1.2

—

Inguinal hernia

105

503

1.40

2.66

1.7

1.6

—

Superficial injury of abdomen, lower back and pelvis

161

1.87

2.65

1.2

1.5

—

Golimumab

3.16

2.64

1.0

2.2

—

Disorders of mineral metabolism

2.22

2.63

1.6

1.3

—

Social phobias

2.21

2.63

1.4

1.5

—

Other diseases of hard tissues of teeth

361

1.42

2.62

1.4

—

Basal cell carcinoma

278

1.54

2.62

1.7

1.5

—

Other bacterial agents as the cause of diseases classified to other chapters

4.72

2.60

1.6

2.3

—

Fracture of lumbar spine and pelvis

213

1.74

2.60

1.3

—

Diseases of spleen

4.70

2.60

1.6

1.3

—

Open wound of ankle and foot

120

2.01

2.60

1.5

1.6

—

Malignant melanoma of skin, including Hilmo

120

2.00

2.60

1.4

1.5

—

Specific personality disorders

282

1.63

2.59

1.1

1.5

—

Dysplasia of cervi uteri

224

1.62

2.58

1.3

—

Small fibre neuropathy

3.62

2.58

1.6

1.7

—

Haemorrhoids and perianal venous thrombosis

352

1.56

2.57

1.6

1.4

—

Other nutritional deficiencies

128

904

1.33

2.57

1.5

—

Other diseases of pancreas

2.19

2.57

1.4

1.3

—

Dissection of aorta

4.02

2.57

1.0

1.2

—

Malignant neoplasm, without specification of site

4.02

2.57

1.0

1.2

—

Amputation of thigh

4.02

2.57

1.1

1.3

—

Hypersensitivity angiitis

7.30

2.56

1.0

1.4

—

Acute drug-induced interstitial lung disorder

7.25

2.56

1.4

1.1

—

Abnormality of white blood cells, not elsewhere classified

7.24

2.56

1.0

1.1

—

Other retinal disorders

108

613

1.37

2.55

1.4

1.6

—

Generalized skin eruption due to drugs and medicaments

2.87

2.55

1.8

1.6

—

Trigger finger

142

1.91

2.54

1.2

1.4

—

Certain conditions originating in the perinatal period

113

1.97

2.53

1.4

1.8

—

Radial styloid tenosynovitis [de Quervain]

2.61

2.53

1.7

1.3

—

Tongue abnormality

2.51

2.53

1.2

1.4

—

Angina pectoris

423

1.42

2.51

1.7

1.2

—

Congenital malformations and deformations of the musculoskeletal system

142

1.90

2.51

1.6

1.8

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

209

1.72

2.51

1.4

1.7

—

Crossbite

2.13

2.50

2.9

1.8

—

Other strabismus

284

1.62

2.50

1.3

1.5

—

Acne

115

2.00

2.49

1.9

1.7

—

Acute laryngitis and tracheitis

120

1.97

2.49

1.6

1.2

—

Hypoparathyroidism

2.99

2.49

1.7

1.3

—

Viral agents as the cause of diseases classified to other chapters

3.48

2.48

1.3

2.1

—

Disorders of muscles

2.11

2.48

1.2

1.5

—

Other and unspecified psoriasis

2.33

2.48

1.3

1.5

—

Amyloidosis, other/unspecified

4.41

2.48

1.1

1.2

—

Pyoderma

4.41

2.48

1.1

2.2

—

KRA_PSY_EATING, excluding more controls

2.26

2.47

1.3

1.6

—

Superficial injury of thorax

158

1.84

2.47

1.4

—

Delirium, not induced by alcohol and other psychoactive substances

2.11

2.47

1.3

1.5

—

Psoriasis

341

1.56

2.47

1.2

1.5

—

Melanocytic naevi of scalp and neck

3.83

2.46

2.0

1.4

—

Other (seronegative) rheumatoid arthritis, wide

195

1.75

2.45

1.1

1.5

—

Chronic periodontitis, complicated

672

1.39

2.45

1.9

1.5

—

Diseases of external ear

414

1.50

2.44

1.2

1.6

—

Desensitization to allergens

2.56

2.44

1.4

1.9

—

Myocardial infarction

368

1.45

2.44

1.5

1.2

—

Gonococcal infection

3.14

2.43

1.2

1.3

—

Pyothorax

3.14

2.43

1.3

1.5

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

219

1.69

2.42

1.4

1.7

—

Specific development disorders of speech and language

2.14

2.41

1.7

1.9

—

Hepatomegaly and splenomegaly, not elsewhere classified

5.06

2.41

1.7

1.1

—

Other immunodeficiencies

5.06

2.41

1.8

1.2

—

Anorexia

5.04

2.40

1.8

—

Abscess of lung

5.04

2.40

1.0

1.3

—

Malignant neoplasm of eye and adnexa, including Hilmo

5.04

2.40

2.7

1.2

—

Abnormal results of function studies

2.17

2.40

2.4

1.6

—

Weight loss

110

2.01

2.40

2.0

1.5

—

Systemic sclerosis (FG)

3.36

2.39

2.3

1.2

—

Other and unspecified injuries of shoulder and upper arm

3.35

2.39

2.3

1.2

—

Other disorders of the musculoskeletal system and connective tissue

160

1.82

2.38

1.4

1.5

—

Sequelae of infectious and parasitic diseases

2.35

2.38

1.3

1.6

—

Universal erythroderma, KELA reimbursement

6.30

2.37

1.0

1.4

—

Exposure to other and unspecified inanimate mechanical forces

2.21

2.37

1.2

1.8

—

Other and unspecified injuries of lower leg

2.21

2.37

2.1

1.5

—

Benign neoplasm of other and ill-defined parts of digestive system

190

1.74

2.36

1.9

1.3

—

Pollen allergy

255

1.63

2.36

1.5

1.6

—

Atopic conjunctivitis

2.62

2.36

1.7

1.6

—

Foreign body or object entering through skin

2.51

2.36

1.3

1.8

—

Major coronary heart disease event excluding revascularizations

451

1.39

2.35

1.5

1.2

—

Haemorrhagic and haematological disorders of fetus and newborn

2.87

2.35

1.7

2.5

—

Other and/or unspecified nontoxic goitre

2.09

2.32

1.2

1.3

—

Ischaemic Stroke, excluding all haemorrhages

488

1.39

2.32

1.3

1.6

—

Hydrocele

2.04

2.31

1.4

1.8

—

Chronic hepatitis, not elsewhere classified

3.23

2.31

1.2

1.7

—

Lichen simplex chronicus

3.23

2.31

1.0

1.4

—

Spontaneous rupture of synovium and tendon

2.18

2.30

1.6

1.5

—

Other disorders of bladder

105

2.00

2.30

1.3

—

Specific development disorders of scholastic skills

2.48

2.29

2.1

1.8

—

Visual impairment including blindness (binocular or monocular)

2.38

2.29

1.8

1.5

—

Benign neoplasm: Sigmoid colon

192

1.72

2.29

1.2

1.4

—

Residual foreign body in soft tissue

2.46

2.27

1.2

1.6

—

Right hemicolectomy

2.46

2.27

1.5

1.4

—

Disorders in reading

4.65

2.27

2.7

1.6

—

Other disorders of pigmentation

2.76

2.27

3.2

1.4

—

Other coagulation defects

2.23

2.27

1.8

1.5

—

Mental and behavioural disorders due to cannabinoids

3.49

2.27

1.0

2.3

—

Other congenital malformations of skin

2.07

2.27

1.8

1.9

—

Other arthrosis

432

1.40

2.26

1.3

1.7

—

Heart failure and hypertrophic cardiomyopathy

3.92

2.25

1.0

1.2

—

Polycystic ovarian syndrome, consortium definition

135

612

1.31

2.25

1.5

1.3

—

Injury of nerves and spinal cord at neck level

3.91

2.25

1.0

1.4

—

Anaemia in chronic diseases classified elsewhere

3.91

2.25

1.0

1.4

—

Malignant neoplasm of liver and intrahepatic bile ducts

3.91

2.25

1.3

1.0

—

Other sexually transmitted chlamydial diseases

106

1.99

2.25

1.1

1.3

—

Use of antiglaucoma preparations and miotics

2.28

2.24

1.8

1.3

—

Open wound of head

698

1.35

2.23

1.3

1.6

—

Other bullous disorders

3.12

2.23

1.0

1.3

—

Pneumonia derived septicemia

3.12

2.22

1.4

1.9

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

3.11

2.22

1.2

1.5

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

5.63

2.22

1.2

1.3

—

Myelodysplastic syndrome

5.61

2.22

1.4

1.0

—

Malignant neoplasm of tonsil, including Hilmo

5.59

2.21

2.0

1.0

—

Sacrococcygeal disorders, not elsewhere classified

2.87

2.21

1.0

1.4

—

Arthropathies in other diseases classified elsewhere

2.87

2.21

1.6

1.5

—

Sleep disorders, other/unspecified

2.87

2.21

1.0

1.6

—

Somnolence, stupor and coma

2.87

2.21

1.4

1.6

—

Retinal haemorrhage

3.35

2.18

3.5

1.2

—

Emotionally unstable personality disorder

143

1.82

2.18

1.1

1.4

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

3.35

2.18

1.1

1.7

—

Ulcerative enterocolitis

3.35

2.18

1.0

1.7

—

Hypertrophy of breast in women and men

226

1.64

2.16

1.2

1.5

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

3.71

2.15

3.0

1.5

—

Toxic liver disease

4.32

2.15

1.5

—

Other specified/unspecified deforming dorsopathies

3.71

2.15

1.9

2.0

—

Parapsoriasis

4.31

2.15

1.2

1.1

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

151

1.79

2.15

2.0

1.6

—

Amputation of foot

3.70

2.15

1.1

1.7

—

Loose body in joint

4.31

2.15

3.0

2.9

—

Other disorders of male genital organs

3.70

2.15

1.0

2.4

—

Symptoms and signs involving the nervous and musculoskeletal systems

105

790

1.33

2.14

1.5

1.6

—

Nonspecific lymphadenitis

2.30

2.14

1.1

1.6

—

Lack of expected normal physiological development

4.39

2.14

2.7

1.0

—

Special screening examination for neoplasms

2.63

2.14

2.3

1.2

—

Abdominal aortic aneurysm (AAA)

2.22

2.13

1.3

—

Insulin, fast-acting

436

1.45

2.12

1.8

1.5

—

Fibromyalgia

2.05

2.11

1.1

1.2

—

Insulin, intermediate and long-acting

678

1.35

2.10

1.4

1.6

—

Nonsuppurative otitis media

285

1.52

2.10

1.7

1.5

—

Dorsopathies

196

804

1.24

2.10

1.5

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

499

1.36

2.10

1.3

—

Other and unspecified epidermal thickening

3.22

2.09

3.3

1.9

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

3.21

2.09

1.0

1.2

—

Cerebrovascular diseases

124

670

1.30

2.08

1.5

1.6

—

Non-small cell lung cancer, adenocarcinoma

2.57

2.08

1.1

1.3

—

Tinnitus

268

1.57

2.07

1.4

1.5

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

5.04

2.07

1.0

1.3

—

Other disorders of central nervous system

5.04

2.07

1.0

1.3

—

Brain glioblastoma

5.04

2.07

1.0

—

Colitis, primary sclerosing

5.04

2.07

1.0

1.2

—

Other and unspecified paralytic syndromes

5.03

2.07

1.2

1.4

—

Other sexually transmitted chlamydial diseases

2.26

2.07

1.1

1.4

—

Pneumococcal septicemia

2.92

2.07

1.4

1.9

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

3.52

2.06

1.1

2.0

—

Behavioural disorders

3.52

2.06

1.0

1.5

—

Other disorders of glucose regulation and pancreatic internal secretion

2.03

2.05

1.9

1.7

—

All dysplastic lesions of the cervix uteri

322

1.51

2.05

1.2

1.3

—

Disorders of refraction and accommodation

364

1.48

2.05

1.7

1.5

—

Other general symptoms and signs

2.68

2.04

2.1

1.2

—

Helminthiases

4.03

2.04

3.2

1.3

—

Malignant neoplasm of small intestine

4.02

2.04

2.2

1.2

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

154

1.76

2.03

1.4

1.5

—

Other peripheral vascular diseases

2.11

2.02

1.7

1.3

—

Meniscus derangement

464

1.35

2.02

1.2

1.7

—

Cerebral palsy and other paralytic syndromes

118

1.87

2.01

1.5

—

Polypectomy (DHB20)

2.23

2.01

2.2

1.4

—

Dermatographic urticaria

2.23

2.01

2.6

1.2

—

Unspecified jaundice

2.64

2.00

1.1

1.2

—

Other aneurysm

2.64

2.00

2.4

1.4

—

Psoriatic and enteropathic arthropathies

111

1.90

2.00

1.3

1.7

—

Injury of eye and orbit

155

1.74

1.99

1.3

1.5

—

Cardiac arrest

2.85

1.99

1.6

1.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

193

1.66

1.99

1.1

1.5

—

Abnormal findings on diagnostic imaging of other body structures

133

1.81

1.99

1.1

1.3

—

Rheumatism, unspecified

133

1.81

1.99

1.3

—

Type 1 diabetes

319

1.50

1.98

1.3

1.5

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.15

1.98

1.1

1.9

—

Other disorders of ear

167

878

1.25

1.98

1.7

1.5

—

Other bursopathies

126

1.83

1.97

1.3

1.5

—

Other melanin hyperpigmentation

3.35

1.97

2.9

1.2

—

Papilloedema, unspecified

3.35

1.97

3.9

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

369

1.47

1.96

1.3

1.4

—

Conduct disorder

3.35

1.96

1.0

2.2

—

Astigmatism

2.08

1.95

1.1

2.2

—

Non-invasive ventilation

207

1.60

1.95

2.2

1.3

—

Suggestive for eosinophilic asthma

2.03

1.95

1.6

1.4

—

Disorders of optic nerve and visual pathways

105

1.91

1.95

2.4

1.5

—

Chronic hepatitis NAS

4.58

1.94

1.2

1.3

—

Unspecified fall

672

1.34

1.94

1.4

1.5

—

Open wound of thorax

4.57

1.94

1.0

3.2

—

Hypercalcemia

2.57

1.94

1.8

1.2

—

Family history of other conditions

3.78

1.94

1.3

—

Meralgia paraesthetica

2.97

1.93

2.1

1.6

—

Malignant cancer of tonsil and base of tongue, including Hilmo

3.77

1.93

2.0

1.6

—

Alcohol-induced acute pancreatitis

2.97

1.93

1.0

1.6

—

Diseases of the myoneural junction and muscle

127

1.81

1.93

1.3

1.6

—

Chronic diseases of tonsils and adenoids

147

737

1.26

1.93

1.4

1.5

—

Mental and behavioural disorders due to opioids

2.74

1.93

2.1

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

2.45

1.93

1.2

1.3

—

Eustachian salpingitis and obstruction

2.12

1.92

1.1

1.6

—

Cervicocranial syndrome

113

1.86

1.91

1.6

1.5

—

Heartburn

113

1.86

1.91

1.1

1.3

—

Unspecified haematuria

396

1.40

1.91

1.9

1.6

—

Trigeminal neuralgia

2.25

1.90

1.8

1.4

—

Liveborn infants according to place of birth

3.75

1.90

1.3

2.9

—

Diseases of peritoneum

106

1.89

1.90

1.2

1.4

—

Psoriasis vulgaris

219

1.60

1.90

1.2

1.5

—

Acne vulgaris

2.00

1.90

2.2

1.7

—

Hallux valgus (acquired)

265

1.47

1.89

1.4

1.6

—

Exclusions for E4_PCOS_CONSORTIUM

137

677

1.27

1.89

1.7

1.4

—

Other symptoms and signs involving the digestive system and abdomen

173

1.68

1.89

1.8

1.3

—

Viral agents as the cause of diseases classified to other chapters

3.20

1.88

1.3

2.2

—

Alopecia areata

3.20

1.88

1.9

1.6

—

Status epilepticus

3.19

1.88

1.1

1.7

—

Retinal detachments and breaks

398

1.43

1.87

1.5

—

Erosion of teeth , including avohilmo

316

1.49

1.87

1.7

1.4

—

Other erythematous conditions

2.66

1.86

1.4

1.3

—

Abnormal blood-pressure reading, without diagnosis

2.65

1.86

1.2

1.5

—

Acute bronchiolitis

1.96

1.86

1.7

2.0

—

Scar conditions and fibrosis of skin

2.40

1.85

1.6

1.2

—

Labour and delivery complicated by umbilical cord complications

0.00

1.85

0.0

1.3

—

Idiopathic gout

2.03

1.85

1.5

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

563

1.32

1.84

1.6

1.5

—

Vitamin D deficiency

3.55

1.84

2.7

1.8

—

Suicide or other Intentional self-harm

293

1.50

1.83

1.3

1.4

—

Dentofacial anomalies [including malocclusion]

131

833

1.26

1.83

1.7

1.4

—

Congenital malformations of cardiac chambers and connections

4.23

1.83

1.4

2.7

—

Disorders of porphyrin and bilirubin metabolism

4.20

1.83

2.6

1.3

—

Congenital musculoskeletal deformities of head, face, spine and chest

4.20

1.82

1.0

2.4

—

Hypotension due to drugs

4.20

1.82

1.8

1.3

—

Hepatocellular carcinoma

4.19

1.82

1.2

1.0

—

Hypertrophy of breast

206

1.60

1.82

1.2

1.5

—

Other disorders of veins

490

1.38

1.82

1.2

1.4

—

Polyarthrosis

198

1.60

1.82

1.5

—

Crohn's disease of small intestine

2.13

1.81

1.2

1.8

—

Pacemaker

328

1.46

1.81

1.6

1.4

—

105

714

1.30

1.81

1.3

1.6

—

Disease of hard tissues of teeth, NOS

347

1.34

1.81

1.5

1.4

—

100

694

1.30

1.80

1.4

1.6

—

Fracture of neck

2.27

1.80

1.0

1.4

—

Superficial injury of wrist and hand

254

1.54

1.80

1.5

—

Viral meningitis

2.58

1.80

1.4

2.0

—

Separation of retinal layers (serosa)

2.58

1.80

1.1

2.0

—

Toxic effect of ethanol

2.58

1.80

1.0

2.3

—

L02BG Aromatase inhibitors

343

1.46

1.80

1.1

1.4

—

Hydronephrosis

1.92

1.79

1.0

1.4

—

Neonatal jaundice from other and unspecified causes

2.59

1.79

1.9

2.7

—

Other specified and unspecified retinal disorders

2.77

1.79

1.8

1.7

—

Event of undetermined intent

2.17

1.77

1.8

—

Benign neoplasm: Ascending colon

146

1.72

1.77

1.4

—

Assault

146

1.72

1.77

1.0

1.5

—

Cholecystitis

131

1.76

1.77

1.5

1.2

—

Gonarthrosis [arthrosis of knee](FG)

119

541

1.28

1.76

1.3

1.6

—

Benign neoplasm: Skin of eyelid, including canthus

169

1.66

1.76

1.2

1.4

—

Non-small cell lung cancer

1.99

1.76

1.1

1.3

—

Other enthesopathy of foot (+metatarsalgia)

102

1.87

1.76

1.2

1.3

—

HSIL lesion of the cervix uteri, vagina or vulva

256

1.53

1.75

1.2

1.3

—

Other fall from one level to another

272

1.51

1.75

1.1

1.6

—

Malignant melanoma

117

1.80

1.74

1.6

1.4

—

Gonococcal infection

2.68

1.72

1.0

1.3

—

Congenital deformities of hip

2.93

1.72

1.3

3.1

—

Manic episode

2.93

1.72

2.4

1.8

—

Lumbar disc prolapse

111

666

1.28

1.72

1.7

1.5

—

Exclusions for E4_PCOS_BROAD

217

1.57

1.72

2.2

1.6

—

Malignant neoplasm of vulva, including Hilmo

3.87

1.72

1.2

—

Congenital musculoskeletal deformities of head, face, spine and chest

3.87

1.72

1.0

2.8

—

Other congenital malformations of peripheral vascular system

3.87

1.72

1.6

2.0

—

Congenital malformations of heart and great arteries

165

1.65

1.71

1.6

1.9

—

Bell's palsy

125

1.76

1.71

1.5

1.6

—

Spondyloarthritis

186

1.61

1.71

1.1

1.4

—

Biomechanical lesions, not elsewhere classified

2.30

1.70

1.2

1.4

—

Use of memantine

213

0.51

1.70

1.2

—

Use of other anti-dementia drugs

213

0.51

1.70

1.2

—

N06DA Anticholinesterases

274

0.57

1.70

1.5

1.3

—

Use of anticholinesterases

274

0.57

1.70

1.5

1.3

—

Benign neoplasm: Descending colon

2.06

1.70

1.5

1.4

—

Injuries to the hip and thigh

529

1.34

1.70

1.5

—

Retinal detachment with retinal break

133

1.73

1.69

1.6

1.4

—

Hypoglycaemia, other or unspecified

2.00

1.69

1.9

1.8

—

Hyperplasia of prostate

213

1.44

1.69

1.8

—

Duodenal ulcer

1.95

1.69

1.3

—

Hyperkinetic disorders, excluding more controls

106

1.81

1.68

1.1

1.5

—

Type 2 diabetes, wide definition

134

687

1.25

1.67

1.6

1.5

—

Benign neoplasm: Colon, unspecified

259

1.51

1.67

1.6

1.5

—

Conduction disorders

255

1.46

1.66

1.5

—

Mental and behavioural disorders due to psychoactive substance use

104

754

1.28

1.66

1.5

1.6

—

HSIL lesion of the vulva

3.18

1.66

1.0

1.4

—

Foreign body in ear

3.17

1.66

1.0

1.7

—

Enteropathic arthropathies

3.17

1.66

1.3

1.8

—

Post-traumatic wound infection, not elsewhere classified

3.17

1.66

2.2

1.8

—

Malignant neoplasm of bladder, including Hilmo

1.94

1.66

2.4

1.5

—

Sleep apnoea, including avohilmo

177

905

1.21

1.66

1.6

1.5

—

Dementia, including avohilmo

364

0.66

1.65

1.5

1.4

—

Granulomatous disorders of skin and subcutaneous tissue

2.81

1.65

1.4

1.3

—

Benign neoplasm: Skin of lower limb, including hip

2.81

1.65

2.1

1.4

—

Congenital deformities of hip

2.81

1.65

1.3

3.0

—

Other specified and unspecified personality disorders

1.89

1.65

1.2

1.6

—

Brachial plexus disorders

1.89

1.65

1.2

1.6

—

Other shoulder lesions

1.89

1.65

1.9

1.5

—

Bipolar affective disorders

196

1.58

1.65

1.3

1.4

—

Obesity

115

881

1.26

1.64

1.4

1.5

—

Single delivery by caesarean section

184

0.56

1.64

1.1

1.3

—

Post-traumatic stress disorder

1.93

1.64

1.7

1.4

—

Memory loss

1.98

1.64

1.3

—

Dislocation, sprain and strain of joints and ligaments of knee

108

784

1.27

1.64

1.2

1.5

—

Insulin, fast-acting or short human

460

1.37

1.64

1.8

1.5

—

Melanocytic naevi of lower limb, including hip

2.25

1.63

2.6

1.5

—

Abnormal involuntary movements

150

1.67

1.63

1.3

1.5

—

Benign neoplasm of mouth and pharynx

105

1.81

1.62

1.3

1.5

—

Sleep apnoea

163

867

1.22

1.62

1.7

1.4

—

Carcinoma in situ of skin, other sites/unspecified

3.60

1.62

3.0

1.2

—

Other and unspecified haemorrhagic conditions

3.59

1.62

1.6

1.4

—

Accidental poisoning by and exposure to alcohol

3.59

1.62

1.0

1.9

—

Rubella [German measles]

3.58

1.61

1.2

1.8

—

Other ulcerative colitis

2.15

1.61

1.4

1.7

—

Olecranon bursitis

2.15

1.61

1.5

1.6

—

Obesity and other hyperalimentation

115

883

1.26

1.60

1.4

1.5

—

Colectomy operation

174

1.61

1.60

1.5

1.4

—

Abnormal serum enzyme levels

311

1.44

1.60

1.5

1.7

—

Congenital iodine-deficiency syndrome/hypothyroidism

2.51

1.60

1.0

1.2

—

Male infertility

2.51

1.59

1.9

2.0

—

Malignant neoplasm of oral cavity, including Hilmo

2.51

1.59

1.3

1.4

—

Ulcerative proctitis

2.07

1.59

1.6

—

Acute gastritis

2.00

1.59

2.3

1.3

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

214

1.54

1.58

1.5

1.6

—

Disorders of optic nerve, not elsewhere classified

3.02

1.58

1.7

1.3

—

Autonomic disorders

3.01

1.58

1.3

1.8

—

Other and unspecified vasculitis limited to skin

3.01

1.58

1.2

—

Primary biliary cholangitis (PBC)

2.71

1.58

1.1

1.3

—

Spondylopathies (FG)

136

1.69

1.58

1.1

1.5

—

Burns and corrosions confined to eye and internal organs

3.01

1.58

2.3

1.8

—

Renal cell carcinoma of kidney

3.01

1.58

1.2

—

Certain zoonotic bacterial diseases

2.70

1.58

1.6

1.3

—

Benign neoplasm: Long bones of lower limb

2.70

1.58

1.0

1.4

—

Stroke, excluding SAH

532

1.29

1.58

1.4

1.6

—

Type 1 diabetes, strict definition, subgroup 1

1.95

1.58

1.2

1.8

—

Disorders of vitreous body and globe

603

1.31

1.57

1.6

1.5

—

Vitamin deficiency

2.21

1.57

2.1

1.5

—

Vitamin deficiency, wide

2.21

1.57

2.1

1.5

—

Cirrhosis of liver, NAS

2.21

1.57

1.3

1.4

—

Carpal tunnel syndrome

102

708

1.27

1.56

1.3

1.5

—

Mental disorders, not otherwise specified

1.85

1.55

1.5

1.6

—

Intestinal malabsorption

2.28

1.55

1.3

1.4

—

Crowding of teeth, including avohilmo

106

1.72

1.55

2.3

1.8

—

Persons encountering health services in other circumstances

497

1.34

1.55

1.5

1.4

—

Contusion of other and unspecified parts of foot

2.11

1.55

1.6

1.8

—

Hypermobility syndrome

2.11

1.55

1.1

1.4

—

Diabetic maculopathy, excluding more controls

107

1.78

1.54

1.5

1.3

—

Conductive and sensorineural hearing loss

131

715

1.24

1.54

1.7

1.5

—

Neuromuscular dysfunction of bladder

1.93

1.54

1.2

1.3

—

Alcohol use disorder, Swedish definition

658

1.28

1.53

1.3

1.6

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

101

630

1.27

1.52

1.3

1.4

—

Hepatocellular carcinoma, including Hilmo

3.34

1.52

1.2

1.0

—

Fracture of foot, except ankle

298

1.44

1.52

1.3

1.4

—

Blepharochalasis

298

1.44

1.52

1.7

1.4

—

Glaucoma

572

1.29

1.52

1.4

1.5

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

2.60

1.51

1.0

2.2

—

Arterial embolism and thrombosis of lower extremity artery

2.60

1.51

1.6

1.5

—

Exclusion endpoint for clefts

2.60

1.51

3.1

2.6

—

LSIL lesion of the cervix uteri

138

1.67

1.51

1.1

1.3

—

Pain and other conditions associated with female genital organs and menstrual cycle

236

1.48

1.51

1.3

—

Other and unspecified disorders of vitreous body

487

1.34

1.50

1.5

—

Fracture of lower leg, including ankle

740

1.27

1.49

1.6

1.5

—

Open wound of forearm

101

1.79

1.48

1.6

1.5

—

Mental and behavioural disorders due to sedatives or hypnotics

2.00

1.48

2.0

1.7

—

Contact with other sharp object(s)

2.00

1.48

1.4

1.7

—

Noninflammatory disorders of female genital tract

305

1.32

1.48

1.5

1.3

—

Early complications of trauma

2.44

1.48

2.2

1.8

—

!Aliquae complicationes praecoces traumatis

2.44

1.48

2.2

1.8

—

Mandibular retrognathia

1.94

1.47

1.4

1.9

—

Other and unspecified effects of external causes

359

1.39

1.47

1.6

1.5

—

Gonarthrosis

102

458

1.27

1.47

1.3

1.7

—

Myopia

147

1.64

1.47

2.3

1.6

—

Necrosis of pulp, including avohilmo

103

819

1.25

1.46

1.6

1.5

—

Disorders of vitreous body

588

1.30

1.46

1.5

—

Benign neoplasm: Transverse colon

109

1.75

1.46

2.2

1.4

—

Pre-eclampsia or poor fetal growth

426

0.65

1.45

1.6

1.3

—

Chronic conjunctivitis

2.38

1.45

1.6

1.7

—

Benign neoplasm: Skin of trunk

2.38

1.45

3.2

1.3

—

Ankylosing spondylitis, strict definition

2.38

1.45

1.1

2.1

—

Other congenital malformations of circulatory system

2.51

1.45

3.4

1.7

—

Allergic purpura

2.51

1.45

1.6

1.2

—

Foreign body entering into or through eye or natural orifice

1.88

1.44

1.9

1.8

—

Crohn's disease of large intestine

2.12

1.44

1.3

1.7

—

Cerebral cysts

2.12

1.44

1.9

1.7

—

Myasthenia gravis

3.14

1.44

1.4

1.2

—

Certolizumab pegol

3.14

1.44

1.0

1.4

—

Cardiomyopathy, Hypertrophic obstructive

3.14

1.44

1.0

1.8

—

Infliximab

3.14

1.44

1.0

1.4

—

2.74

1.43

1.0

1.9

—

Volvulus

2.74

1.43

1.3

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

2.74

1.43

1.0

2.1

—

Alcohol withdrawal state with delirium

2.04

1.43

1.1

1.8

—

Substance abuse

740

1.26

1.43

1.6

—

Premature rupture of membranes

245

0.61

1.43

1.2

—

Oesophageal varices

2.32

1.43

2.8

1.7

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

565

0.72

1.43

1.4

1.3

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

110

1.73

1.42

1.7

1.8

—

Pregnancy hypertension

529

0.71

1.42

1.4

1.3

—

Allergic contact dermatitis

141

1.63

1.41

1.4

—

Ganglion

237

1.48

1.41

1.5

—

Temporomandibular joint disorders, including avohilmo

596

1.29

1.40

1.2

1.4

—

Disorders of breast

596

1.28

1.40

1.2

1.4

—

Postmenopausal atrophic vaginitis

183

1.42

1.40

1.1

1.4

—

Sequelae of other and unspecified infectious and parasitic diseases

2.18

1.40

1.3

1.8

—

Other demyelinating diseases of the central nervous system

2.42

1.39

2.3

1.4

—

Nonalcoholic fatty liver disease

111

1.72

1.39

1.2

1.6

—

Metatarsalgia

1.77

1.38

1.2

1.3

—

Malignant neoplasm of rectum, including Hilmo

1.77

1.38

1.2

1.5

—

Unspecified misadventure during surgical and medical care

2.08

1.38

1.1

1.4

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

2.08

1.38

1.1

1.4

—

Paralytic strabismus

1.94

1.38

1.5

—

Other osteochondropathies

1.94

1.38

1.8

1.9

—

Maternal care for known or suspected fetal abnormality and damage

197

1.49

1.38

1.4

1.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

525

1.31

1.38

1.6

1.5

—

Pyogenic arthritis

2.00

1.38

1.3

1.6

—

Persons encountering health services in circumstances related to reproduction

106

573

1.25

1.37

1.8

1.5

—

Diabetic retinopathy, excluding more controls

122

1.52

1.37

1.6

1.9

—

Congenital malformations of aortic and mitral valves

2.20

1.37

1.6

2.3

—

Vasculitis limited to skin, not elsewhere classified

2.62

1.37

1.2

1.3

—

Other specified congenital malformation syndromes affecting multiple systems

2.62

1.37

3.0

2.8

—

Calculus of kidney and ureter

339

1.39

1.37

2.0

1.5

—

Tooth eruption problems

193

1.52

1.36

2.0

1.6

—

Other mental disorders due to brain damage and dysfunction and to physical disease

104

1.73

1.36

1.2

1.4

—

Isolated growth hormone deficiency

2.98

1.36

4.2

2.6

—

Abnormalities of gait and mobility

127

1.66

1.36

1.2

1.5

—

Dementia

340

0.69

1.36

1.5

1.4

—

Abnormal findings in nipple discharge synovial fluid wound secretions

2.96

1.36

1.4

—

Sub-endpoint used in defining T1D endpoints

342

1.38

1.36

1.3

1.5

—

Amputation of ankle bones

2.95

1.36

1.4

1.2

—

Endometriosis ASRM stages 3,4

286

0.59

1.35

1.1

1.3

—

Visual field defects

1.83

1.35

1.1

1.5

—

Primary gonarthrosis, bilateral

550

0.73

1.34

1.2

1.6

—

Vascular disorders of the intestines

2.13

1.33

1.2

—

Benign neoplasm of eye and adnexa

105

1.72

1.33

1.9

1.3

—

Disorders of continuity of bone

105

1.72

1.33

1.1

1.5

—

Pneumonitis due to solids and liquids

1.97

1.32

2.6

1.3

—

Obesity due to excess calories

655

1.27

1.32

1.4

1.5

—

Unspecific neurodegenerative disorder

311

0.68

1.31

1.4

1.3

—

Congenital malformations of genital organs

120

1.66

1.31

1.5

—

Other localized connective tissue disorders

2.51

1.30

1.2

—

Psoriasis (vulgaris), strict definition

2.51

1.30

1.0

2.2

—

Fracture of skull and facial bones

242

1.45

1.29

1.3

1.5

—

Benign neoplasm: Skin of other and unspecified parts of face

106

1.70

1.29

1.9

1.3

—

Cerebral palsy

2.79

1.28

1.6

1.8

—

Contact with sharp object, undetermined intent

2.79

1.28

1.2

2.4

—

Disorders of globe

2.79

1.28

3.2

1.2

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

2.79

1.28

1.0

—

Other obstetric conditions, not elsewhere classified

298

1.32

1.28

1.3

—

Later onset COPD

192

1.45

1.28

1.3

1.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

1.94

1.27

1.0

1.8

—

Crohn disease (strict definition, require KELA)

1.94

1.27

1.0

1.8

—

Pregnancy, childbirth and the puerperium

237

0.68

1.27

1.4

1.3

—

Aortic valve malfunction, age under 60 years

1.72

1.27

1.8

—

Helminthiases

2.05

1.27

3.7

1.6

—

AV-block

134

1.57

1.26

1.7

1.5

—

Other disorders of the genitourinary system

138

1.60

1.26

1.0

1.3

—

Other maternal disorders predominantly related to pregnancy

541

0.78

1.24

1.4

—

Abnormal spermatozoa

117

0.43

1.24

1.6

—

Lactose intolerance, other/unspecified

2.41

1.24

1.3

1.5

—

Essential (haemorrhagic) thrombocythaemia

2.41

1.24

1.2

1.6

—

Disorders of orbit

2.23

1.24

2.0

1.3

—

Multiple gestation

119

0.42

1.24

1.0

1.2

—

Delivery, wide proxy

283

0.71

1.24

1.3

—

Corns and callosities

1.86

1.24

1.3

—

Benign neoplasm of ovary

190

0.53

1.23

1.2

1.4

—

Other juvenile arthritis

2.01

1.23

1.0

2.1

—

Spinal stenosis

460

1.27

1.23

1.7

1.5

—

Type 1 diabetes, wide definition, subgroup 1

253

1.42

1.23

1.2

1.5

—

Ventral hernia

245

1.43

1.22

1.1

1.5

—

Injuries to the wrist and hand

180

1068

1.17

1.22

1.6

1.5

—

Macular hole

1.97

1.22

1.4

—

Tuberculosis

2.04

1.22

2.1

1.2

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

2.64

1.22

1.0

1.6

—

Other and specified injuries of hip and thigh

2.64

1.21

2.0

1.3

—

Acute nasopharyngitis (common cold)

115

1.64

1.21

1.5

1.6

—

Cyst of Bartholin Gland

2.17

1.21

1.1

1.4

—

Acute appendicitis

122

948

1.20

1.21

1.3

1.5

—

Ventricular septal defect, a heart condition

2.17

1.21

1.8

2.3

—

Maternal care for other known or suspected fetal problems

238

0.66

1.21

1.4

1.2

—

Sensorineural hearing loss

122

686

1.21

1.7

1.6

—

Toxic effects of substances chiefly nonmedicinal as to source

132

1.59

1.20

1.1

1.7

—

Lichen sclerosus et atrophicus

101

1.69

1.19

1.2

1.3

—

Bronchitis, not specified as acute or chronic

1.83

1.19

1.9

1.3

—

False labour

285

0.70

1.19

1.2

1.3

—

Malnutrition

2.32

1.19

1.7

1.4

—

Chorioretinal inflammation

2.31

1.19

1.5

1.7

—

Congenital malformations of the respiratory system

2.32

1.18

1.0

1.6

—

Bulimia nervosa (incl. atypical)

2.11

1.18

1.0

1.4

—

Extreme obesity with alveolar hypoventilation

2.11

1.18

1.8

1.6

—

Calcific aortic valvular stenosis, including rheumatic fever

288

1.38

1.18

1.3

1.4

—

Dental caries, including avohilmo

128

544

1.20

1.18

1.6

1.5

—

Diseases of pulp and periapical tissues, including avohilmo

192

856

1.16

1.18

1.5

—

Biguanides

119

871

0.83

1.18

1.5

—

Obesity, other/unspecified

445

1.30

1.17

1.4

1.5

—

Otitis externa, unspecified

125

1.60

1.17

1.5

1.6

—

Other peripheral vertigo

1.71

1.17

1.1

1.3

—

Left ventricular outflow tract obstruction, narrow definition

2.00

1.16

1.5

2.1

—

Biological medicines for asthma

2.51

1.15

1.0

1.9

—

Other symptoms and signs involving the nervous and musculoskeletal systems

552

1.27

1.15

1.6

1.5

—

Congenital malformations of uterus and cervix

2.51

1.15

1.0

1.4

—

Other specific arthropathies, wide

2.51

1.15

1.0

1.5

—

Other abnormal findings of blood chemistry

2.06

1.15

3.5

1.6

—

Paracetamol or NSAID medication

110

1.47

1.15

1.6

1.3

—

Diabetic retinopathy

211

1.36

1.15

1.6

1.7

—

Stroke, including SAH

574

1.23

1.14

1.4

1.6

—

Radiculopathy

166

1.51

1.14

1.5

1.4

—

Endometriosis of ovary

205

0.57

1.14

1.2

1.4

—

Urolithiasis

360

1.33

1.14

1.9

1.5

—

Type 1 diabetes, strict definition

1.72

1.14

1.2

1.8

—

Deforming dorsopathies

369

1.33

1.13

2.1

1.5

—

Benign neoplasm: Adrenal gland

1.75

1.12

1.1

1.3

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

1.75

1.12

1.3

1.5

—

Benign neoplasm: Conjunctiva

2.34

1.12

1.1

1.6

—

Open wound of abdomen, lower back and pelvis

2.34

1.12

2.4

1.9

—

Polyarthritis, unspecified

2.34

1.12

1.7

1.5

—

Cluster headache, strict

2.34

1.12

2.0

1.4

—

Respiratory tuberculosis, confirmed and not-confirmed

2.00

1.12

2.4

1.2

—

Respiratory tuberculosis

2.00

1.12

2.4

1.2

—

Twin gestation

114

0.44

1.12

1.0

1.3

—

2.00

1.11

1.4

1.2

—

Squamous cell neoplasms and carcinomas of the skin

1.96

1.11

1.7

1.3

—

Muscle strain

2.26

1.10

1.4

1.3

—

Hepatic failure, not elsewhere classified

2.26

1.10

1.6

1.5

—

Medical abortion

112

503

1.21

1.10

1.3

1.4

—

Excessive vomiting in pregnancy

1.67

1.10

1.3

—

Hypocalcemia

2.39

1.09

1.4

1.7

—

Melanocytic naevi of upper limb, including shoulder

2.39

1.09

2.2

1.5

—

Oral leukoplakia, including avohilmo

2.39

1.09

1.0

1.8

—

Pterygium

2.39

1.09

2.0

1.4

—

Other and unspecified mononeuropathies, also in other diseases

2.39

1.09

2.8

1.9

—

Myocardial infarction, strict

350

1.28

1.09

1.4

1.2

—

Internal derangement of knee

466

1.28

1.08

1.3

1.7

—

Gestational [pregnancy-induced] hypertension

351

0.68

1.08

1.4

1.3

—

Disorder of lipoprotein metabolism, unspecified

112

1.61

1.08

1.7

1.3

—

Appendectomy

113

904

1.20

1.08

1.3

1.5

—

Other and unspecified erythematous conditions

2.19

1.08

1.6

1.3

—

Mental retardation, excluding more controls

1.95

1.08

1.3

1.9

—

Cluster headache, wide

2.19

1.08

2.0

1.4

—

Simple and mucopurulent chronic bronchitis

2.19

1.08

2.3

1.7

—

Deviated nasal septum

372

1.32

1.08

1.7

1.6

—

Otitis externa

261

1.38

1.07

1.3

1.5

—

Adhesive capsulitis of shoulder

169

1.48

1.06

1.2

1.4

—

Postprocedural disorders of nervous system

1.76

1.06

1.3

1.5

—

Abnormal weight loss

1.65

1.06

2.1

1.4

—

Insulin, fast-acting (human)

153

1.50

1.06

1.1

1.3

—

Congenital malformations of cardiac septa

1.65

1.05

1.5

2.0

—

Algoneurodystrophy

2.13

1.05

1.0

1.2

—

Ectropion of eyelid

2.13

1.05

1.1

1.2

—

Calcific aortic valvular stenosis, diagnosis (helper)

287

1.35

1.05

1.3

1.4

—

Operations 2 for CAVS

287

1.35

1.05

1.3

1.4

—

Use of rivastigmine

123

0.49

1.04

2.3

1.2

—

Impacted maxillary molar

1.79

1.04

2.9

1.4

—

Orchitis and epididymitis

1.79

1.04

1.5

1.9

—

HSIL lesion of the cervix uteri

237

1.39

1.04

1.2

1.3

—

Single delivery by forceps and vacuum extractor

161

0.64

1.04

1.4

1.2

—

Chronic suppurative otitis media, including avohilmo

1.67

1.04

1.7

1.9

—

Perioral dermatitis

2.28

1.03

1.2

1.4

—

Other epidermal thickening

1.96

1.03

3.4

1.6

—

Other and unspecified injuries of ankle and foot

1.96

1.03

1.8

—

Unspecified event, undetermined intent

2.28

1.03

1.0

1.4

—

Mandibular retrognathia AND surgery (BSSO)

2.28

1.03

1.0

1.5

—

Benign neoplasm: Tongue

2.28

1.03

1.2

—

Other facial nerve disorders

2.28

1.03

1.2

1.4

—

Adenocarcinoma and ductal carcinoma of pancreas

2.28

1.03

1.0

1.5

—

Distal bite

1.95

1.03

2.7

1.6

—

Kela-code for severe mental illness

475

0.74

1.03

1.3

1.5

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

2.06

1.03

1.0

1.9

—

Benign neoplasm: Small intestine

2.06

1.03

1.3

1.5

—

Follow-up care involving plastic surgery

2.06

1.03

1.0

1.2

—

Chronic tubulo-interstitial nephritis

2.06

1.03

1.1

1.3

—

Complications of labour and delivery

522

0.81

1.02

1.4

—

Ascites

1.74

1.02

1.9

1.2

—

Pregnancy examination and test

125

1.44

1.02

1.3

1.2

—

Other/unspecified rheumatoid arthritis

122

1.56

1.02

1.0

1.3

—

Sequelae of cerebrovascular disease

331

1.30

1.02

1.3

1.5

—

Generalized anxiety disorder

171

1.46

1.02

1.2

1.4

—

Fall on same level involving ice and snow

798

1.20

1.01

1.4

1.5

—

Intestinal adhesions without obstruction

1.69

1.01

1.3

1.2

—

Abscess of anal and rectal regions

1.69

1.01

1.8

1.3

—

Adenomyosis (Endometriosis of uterus)

163

1.47

1.01

1.2

1.4

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

293

1.28

1.01

1.3

—

Postprocedural musculoskeletal disorders, not elsewhere classified

1.77

1.00

1.5

1.4

—

Pre-eclampsia or eclampsia

286

0.66

1.00

1.5

1.4

—

Embolic stroke

2.00

1.00

1.1

1.4

—

Fourth [trochlear] nerve palsy

2.18

0.98

1.0

1.3

—

Chronic mastoiditis

2.18

0.98

1.2

1.7

—

Cholecystectomy

113

824

1.18

0.98

1.5

—

Hyperhidrosis

2.18

0.98

1.0

1.1

—

Mouth breathing

520

1.25

0.98

1.7

1.6

—

Noise effects on inner ear

0.00

0.97

0.0

2.0

—

Calcific aortic valvular stenosis, operated

291

1.33

0.97

1.3

1.4

—

Calcific aortic valvular stenosis

291

1.33

0.97

1.3

1.4

—

Acute appendicitis, no complications

780

1.20

0.97

1.3

1.5

—

Other/unspecified disorders of vestibular function

1.95

0.97

1.0

1.3

—

Fracture at wrist and hand level

467

1.26

0.97

1.7

1.5

—

Hydrocephalus

1.85

0.96

2.6

1.3

—

Other symptoms and signs involving the urinary system

100

1.60

0.96

1.6

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1.74

0.96

1.0

1.7

—

Type 1 diabetes, wide definition

275

1.35

0.96

1.2

1.4

—

Glaucoma-related operations

1.77

0.94

1.1

1.2

—

Injuries to the neck

259

1.35

0.94

1.1

1.5

—

Primary coxarthrosis, bilateral

329

0.70

0.94

1.8

1.3

—

Pre-eclampsia

258

0.66

0.94

1.5

1.3

—

Hidradenitis suppurativa

1.90

0.94

1.1

1.5

—

Disturbances of smell and taste

1.90

0.94

1.9

1.5

—

Impacted teeth

230

1.35

0.94

2.0

1.5

—

Other salmonella infections

1.90

0.94

1.4

1.8

—

Delivery

338

0.78

0.94

1.2

1.3

—

Mental and behavioural disorders due to alcohol

651

1.21

0.94

1.4

1.6

—

Pain associated with micturition

125

1.52

0.93

1.4

1.5

—

Macular cyst

2.23

0.93

1.0

1.3

—

Exposure to other and unspecified animate mechanical forces

2.23

0.93

1.0

1.3

—

Benign neoplasm: Stomach

101

1.59

0.93

1.8

1.3

—

Lichen planus, including avohilmo

200

1.40

0.93

1.3

1.4

—

Disorders of vestibular function (Vertigo)

569

1.23

0.93

1.2

1.4

—

Intracranial injury

762

1.19

0.93

1.1

1.6

—

Eating disorder

109

1.56

0.92

1.3

1.5

—

Juvenile arthritis (FINNGEN)

1.73

0.92

1.0

2.1

—

Other diseases of stomach and duodenum

1.82

0.92

2.6

1.3

—

Superficial injury of ankle and foot

142

1.48

0.92

1.8

1.6

—

Arthrosis

110

510

1.18

0.92

1.3

1.7

—

Benign neoplasm: Other and unspecified parts of mouth

2.15

0.91

1.3

1.6

—

Mixed conductive and sensorineural hearing loss

126

1.51

0.91

1.9

1.4

—

Plantar fascial fibromatosis

1.60

0.90

1.5

1.4

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

429

1.26

0.89

2.0

1.5

—

Oesophageal obstruction

2.07

0.89

1.7

1.4

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

236

1.36

0.89

1.3

1.5

—

Other benign neoplasms of connective and other soft tissue

104

0.48

0.88

1.2

1.5

—

Childhood allergy (age < 16)

201

1.35

0.88

1.4

1.7

—

Other acquired deformities of musculoskeletal system and connective tissue

1.91

0.88

1.6

1.5

—

Convalescence

1.91

0.88

2.1

1.5

—

Postpartum haemorrhage

312

0.73

0.87

1.0

1.3

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

135

792

1.15

0.87

1.5

—

Triptan medication for migraine, single purchase ok

135

792

1.15

0.87

1.5

—

Other deformities of toe(s)

2.00

0.87

1.0

1.2

—

Hypothyroidism, strict autoimmune

115

647

1.17

0.87

1.3

1.5

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

186

1.40

0.86

1.6

1.5

—

Foreign body on external eye

168

0.59

0.86

1.7

1.5

—

Presence of other devices

211

1.37

0.86

1.5

1.1

—

Congenital malformations of the urinary system

1.72

0.86

1.3

2.1

—

Malignant neoplasm of bladder

1.82

0.85

2.5

1.4

—

Other degenerative diseases of the nervous system

222

1.31

0.85

1.9

1.3

—

Embedded and impacted teeth

304

1.28

0.85

2.0

1.4

—

Hypopituitarism

1.67

0.85

3.0

1.9

—

Lactose intolerance

1.94

0.84

1.3

1.4

—

Malignant neoplasm of stomach

1.94

0.84

1.8

1.1

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.78

0.84

2.9

2.3

—

Chronic laryngitis and laryngotracheitis

137

1.46

0.83

1.5

1.2

—

Tuberculosis, IBD comorbidity

1.76

0.83

2.1

1.3

—

malignant neoplasm of female genital organs

128

1.48

0.83

1.7

1.3

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Herpes simplex virus Ag [Presence] in Specimen

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS